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During growth, Neisseria gonorrhoeae releases inflammatory 1,6-anhydro peptidoglycan 
monomers through the action of lytic transglycosylases LtgA and LtgD.  N. gonorrhoeae lacking 
LtgA and LtgD release peptidoglycan multimers rather than monomers.  Because peptidoglycan 
is a known activator of the innate immune system, we sought to understand how the activity of 
LtgA and LtgD influenced host responses to N. gonorrhoeae.  We tested inflammatory responses 
to N. gonorrhoeae using isolate FA1090 and FA1090 with ltgA and ltgD deleted, FA1090 
ΔltgA/ΔltgD.  Both live N. gonorrhoeae and culture supernatants from FA1090 ΔltgA/ΔltgD 
caused increased production of IL-1β and TNF-α in THP1 cells and primary human blood 
dendritic cells. Culture supernatants from FA1090 ΔltgA/ΔltgD, which contain multimeric 
peptidoglycan fragments, were more potent activators of host NOD2 and TLR2, but not TLR4, 
TLR9, or NOD1.  NOD1 was activated equally by peptidoglycan monomers and multimers from 
N. gonorrhoeae, but NOD2 was activated only by multimers.  To explain this, we showed that 
multimeric peptidoglycan digested by LtgA, which produce anhydro monomers, were poor 
stimulators of NOD2, while reducing peptidoglycan monomers produced by host lysozyme were 
potent stimulators of NOD2.  Increased TLR2 activation in response to FA1090 ΔltgA/ΔltgD 
culture supernatants was not the result of activation by peptidoglycan, but the presence of higher 
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levels of TLR2-activating proteins.  These data indicate that LtgA and LtgD allow N. 
gonorrhoeae to evade detection by host TLR2 and NOD2.  
We next tested the roles of NOD2 as well as LtgA and LtgD in N. gonorrhoeae infection 
in vivo.  Nod2
-/-
 mice infected with FA1090 had similar bacterial burdens and persistence of 
infection as wild type mice, confirming in vitro data that wild type N. gonorrhoeae interacts 
minimally with NOD2.  When wild type mice were infected with FA1090 ΔltgA/ΔltgD we 
observed a significantly lower bacterial burden compared to mice infected with FA1090.  
Competitive co-infection with FA1090 revealed a fitness defect for FA1090 ΔltgA/ΔltgD.  There 
was not difference in infection persistence between FA1090 and FA1090 ΔltgA/ΔltgD, though 
less mice were successfully infected with FA1090 ΔltgA/ΔltgD than wild type FA1090.  Overall 




To my parents, who have always encouraged and supported me, and especially my dad, who 






 I would like to thank the numerous people at UNC who have helped me during my years 
here as a graduate student and enhanced my training as a scientist.  First and foremost I would 
like to thank my advisor, Alex Duncan, who bought me coffee one morning in October 2010, 
assuring our future relationship as mentor and mentee.  I cannot thank you enough for your 
willingness to teach a young chemist new microbiology and immunology tricks.   
I would like to thank everyone that I have had the pleasure of working with at UNC’s 
STD-CRC as a member of the Duncan Lab.  Without the help of many of you completing my 
project would not have been possible. To others, I thank you for your continual guidance and 
additional mentorship.   
I have been lucky to have excellent external support outside of the lab. I would like to 
thank my committee for their guidance in the completion of this project and my development as 
a scientist.  I would also like to acknowledge the support from my T32 group, especially Bill 
Miller for your leadership and advice on science writing and presenting.  Finally, I would like to 
thank the faculty at the Eshelman School of Pharmacy who supported my transition and the 
Department of Pharmacology for welcoming me into their program and supporting me through 
my graduate education. 
 This work would not have been possible without the support of my family and friends.  
Luke Roode has served as a constant sounding board on science, grad school, and life from the 
day I started graduate school.  Many thanks as well to my Krav family—Cris Campos, Nikki 
Zane, Janelle Briscoe, and Jaimie Lee—for being wonderful friends and giving me something to 
vii 
 
hit in the evenings.  I would also like to thank my Wisconsin friends that continue to stay in 
touch, especially Mike Malone and Scott Stoker.  Finally, I’d like to thank my boyfriend Angus 
Wan, for doing this crazy long distance back-and-forth thing for the past five years.  Your 





TABLE OF CONTENTS 
 
LIST OF FIGURES ....................................................................................................................... xi 
LIST OF ABBREVIATIONS ....................................................................................................... xii 
Chapter 1 ......................................................................................................................................... 1 
1.1 Introduction ...................................................................................................................... 1 
1.2 Epidemiology of infection and antibiotic resistance ........................................................ 1 
1.3 Sites of infection and clinical manifestations ................................................................... 3 
1.4 The immune response to N. gonorrhoeae ........................................................................ 5 
1.4.1 General innate sensing of bacterial pathogens ............................................................... 5 
1.4.2 Characterization of the immune response to N. gonorrhoeae ........................................ 7 
1.4.3 The role of N. gonorrhoeae surface molecules in the innate and                         
adaptive immune response ...................................................................................................... 9 
1.4.4 Other immune evasion mechanisms of N. gonorrhoeae .............................................. 12 
1.5 N. gonorrhoeae peptidoglycan properties and interactions with the immune system ... 13 
1.5.1 Peptidoglycan fragment release in N. gonorrhoeae ..................................................... 13 
1.5.2 Peptidoglycan recycling in N. gonorrhoeae ................................................................. 14 
1.5.3 Other peptidoglycan modifications .............................................................................. 18 
1.5.4 Immune system recognition of peptidoglycan.............................................................. 19 
1.6 The murine model of N. gonorrhoeae infection ............................................................ 22 
1.7 Vaccination against N. gonorrhoeae .............................................................................. 27 
ix 
 
Chapter 2 ....................................................................................................................................... 34 
2.1 Overview ............................................................................................................................. 34 
2.2 Introduction ......................................................................................................................... 34 
2.3 Materials and Methods ........................................................................................................ 37 
2.3.1 Generation of N. gonorrhoeae ltgA/ltgD mutant .......................................................... 37 
2.3.2 Generation of N. gonorrhoeae culture supernatants ..................................................... 37 
2.3.3 Culture supernatants ..................................................................................................... 38 
2.3.4 Reporter cell lines ......................................................................................................... 38 
2.3.5 Cell Culture and Cytokine Analysis ............................................................................. 38 
2.3.6 Purification of N. gonorrhoeae peptidoglycan fragments ............................................ 39 
2.4 Results ................................................................................................................................. 40 
2.4.1 The N. gonorrhoeae LtgA and LtgD proteins play a role in suppressing                     
the inflammatory cytokine production. ................................................................................. 40 
2.4.2 The N. gonorrhoeae LtgA and LtgD proteins modulate NOD2                                   
and TLR2 receptor signaling. ................................................................................................ 41 
2.4.3 Monomeric and dimeric peptidoglycan fragments from                                                
N. gonorrhoeae differentially stimulate innate immune receptors. ....................................... 42 
2.4.4 N. gonorrhoeae LtgA-generated PGN monomers have diminished                     
capacity to activate NOD2 compared to host lysozyme-generated PGN monomers. ........... 43 
2.5 Discussion ........................................................................................................................... 44 
Chapter 3 ....................................................................................................................................... 54 
3.1 Overview ............................................................................................................................. 54 
3.2 Introduction ......................................................................................................................... 54 
3.3 Materials and Methods ........................................................................................................ 57 
3.3.1 Bacterial strains ............................................................................................................ 57 
x 
 
3.3.2  Experimental murine infection with N. gonorrhoeae .................................................. 58 
3.3.4 Competitive co-infection in mice ................................................................................. 58 
3.3.3 Characterization of inflammation ................................................................................. 59 
3.3.4 Cytokine analysis of mouse derived dendritic cells ..................................................... 59 
3.4 Results ................................................................................................................................. 60 
3.4.1 Mice infected with ∆ltgA/∆ltgD N. gonorrhoeae have a lower                            
bacterial burden compared to infection with wild type ......................................................... 60 
3.4.2 Deletion of ltgA and ltgD does not impact infection persistence in vivo ..................... 60 
3.4.3 Inflammatory responses to FA1090 ΔltgA/ΔltgD in mice ........................................... 61 
3.4.4 The ∆ltgA/∆ltgD N. gonorrhoeae mutant has a fitness defect in                     
competitive infection in vivo ................................................................................................. 62 
3.4.5 NOD2 does not play a role in N. gonorrhoeae pathogenesis in the                        
murine model of infection ..................................................................................................... 63 
3.5 Discussion ........................................................................................................................... 63 
Chapter 4 ....................................................................................................................................... 73 
4.1 Discussion ........................................................................................................................... 73 
4.2 Future Directions ................................................................................................................. 78 
Appendix 1: Construction of FA1090 ΔltgA/ΔltgD (KK) ............................................................ 82 
Appendix 2: FA1090 ΔltgA/ΔltgD (KK) in vitro data .................................................................. 83 
Appendix 3: FA1090 ΔltgA/ΔltgD (KK) in vivo data ................................................................... 86 





LIST OF FIGURES 
Figure 1.1. Current understanding of the immune response to N. gonorrhoeae infection. .......... 30 
Figure 1.2. Structure of the peptidoglycan monomer released by N. gonorrhoeae. ..................... 31 
Figure 1.3. Peptidoglycan recycling in N. gonorrhoeae. .............................................................. 32 
Figure 1.4. Persistence of N. gonorrhoeae is significantly reduced in mice                       
colonized with commensal species Staphylococcus xylosus. ....................................................... 33 
Figure 2.1. Deletion of the ltgA and ltgD genes in N. gonorrhoeae results in                    
increased inflammatory signaling in human monocytes and dendritic cells. ............................... 49 
Figure 2.2. Culture supernatants from N. gonorrhoeae lacking ltgA and ltgD                          
genes exhibit enhanced activation of human NOD2 and TLR2, but not NOD1. ......................... 50 
Figure 2.3. Multimeric PGN and Monomeric PGN released by N. gonorrhoeae                      
LtgA differentially activate NOD1 and NOD2. ............................................................................ 51 
Figure 2.4 PGN digested by LtgA but not human neutrophil lysozyme escapes                  
detection by NOD2. ...................................................................................................................... 52 
Figure 2.5. Summary figure showing N. gonorrhoeae evasion of NOD2                           
signaling through the production of 1,6-anhydro PGN monomers by LtgA and LtgD. ............... 53 
Figure 3.1. Mice infected with FA1090 ΔltgA/ΔltgD have a lower bacterial                         
burden compared to mice infected with wild type N. gonorrhoeae. ............................................ 68 
Figure 3.2. Deletion of ltgA and ltgD does not affect infection persistence                                    
of N. gonorrhoeae in the mouse model. ....................................................................................... 69 
Figure 3.3. Increased inflammatory responses to FA1090 ΔltgA/ΔltgD                                         
in vitro do not replicate in vivo. .................................................................................................... 70 
Figure 3.4. Deletion of ltgA and ltgD in N. gonorrhoeae confers a fitness defect in vivo. .......... 71 
Figure 3.5. NOD2 does not play a role in controlling N. gonorrhoeae infection. ........................ 72 
xii 
 
LIST OF ABBREVIATIONS 
AUC  area under the curve 
BMDC bone marrow derived dendritic cells 
CDC  Centers for Disease Control 
CEACAM carcinoembryonic antigen cell adhesion molecules 
CFU  colony forming units 
CI  competitive index 
iE-DAP D-glutamyl-meso-diaminopimelic acid 
GGI  gonoccocal genetic island 
LLD  lower limit of detection 
LOS  lipooligosaccharide 
LPS  lipopolysaccharide 
MDP  muramyl dipeptide 
NLR nucleotide-binding oligomerization domain and leucine-rich repeat containing 
receptors 
  
NOD1  nucleotide-binding oligomerization domain-containing protein 1 
NOD2  nucleotide-binding oligomerization domain-containing protein 2 
PAMP  pathogen-associated molecular pattern 
PEA  phosphoethanolamine 
PGN  peptidoglycan 
PGRP  peptidoglycan recognition proteins 
PID  pelvic inflammatory disease 
PMN  polymorphonuclear leukocyte 
TLR  toll-like receptor
1 
 
Chapter 1  
Introduction 
1.1 Introduction 
Neisseria gonorrhoeae is an obligate human pathogen responsible for the sexually 
transmitted infection gonorrhea. In the United States it is the second most commonly reported 
sexually transmitted infection to the Centers for Disease Control (CDC), with an estimated 
820,000 new cases each year (Centers for Disease Control, 2012a).  N. gonorrhoeae primarily 
infects the genital tract of both men and women.  Left untreated, gonorrhea can cause 
complications including septic arthritis and sterility in both men and women, and pelvic 
inflammatory disease in women.  In pregnant women with genital tract infection, mother to 
infant transmission can occur during birth, resulting in an infection of the eyes that can lead to 
blindness if left untreated (Laga et al., 1989).  Infection with N. gonorrhoeae can also increase 
susceptibility to acquiring other sexually transmitted infections, including HIV (Kaul et al., 
2008).  In recent years, acquisition of antibiotic resistance by N. gonorrhoeae has made 
gonococcal infections difficult to treat and is emerging as a major public health problem.  A 
better understanding of the mechanisms of N. gonorrhoeae infection pathogenesis is critical for 
the development of new therapeutic approaches, including vaccine development.  
1.2 Epidemiology of infection and antibiotic resistance 
 There were 334,826 cases of gonorrhea reported to the CDC in 2012 (Centers for Disease 
Control, 2012b).  The reported cases represent less than half of all estimated new cases, at least 
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partially because gonorrhea infection is often asymptomatic in women and occasionally 
asymptomatic in men.  Approximately 60% of the cases reported in 2012 occurred in individuals 
aged 15-24 years.  Within that age group, rates are slightly higher among women than men.  
Additionally, infection rates are highest among African-Americans than in other ethnically 
defined subgroups.  Consistent with previous years, reported cases were highest in the southern 
United States. 
 A recent report from the CDC characterized antibiotic resistance in N. gonorrhoeae 
clinical isolates (Centers for Disease Control, 2013).  There were an estimated 246,000 cases of 
antibiotic-resistant gonorrhea in the US in 2011.  Based on the prevalence of cefixime resistance, 
the CDC estimated that there were 11,480 cases of cefixime-resistant N. gonorrhoeae infection. 
Due to the increase in cefixime-resistant cases, the CDC removed cefixime as a therapy for 
treating gonorrhea infection, leaving injectable ceftriaxone as the only first-line antibiotic for 
gonococcal infection (Centers for Disease Control, 2012c).  N. gonorrhoeae resistance to these 
antibiotics is rising.  In 2011, the CDC estimated 3,280 cases had reduced susceptibility to 
ceftriaxone, threatening the last remaining first-line agent for treatment of N. gonorrhoeae.  
Globally, the threat of drug-resistant N. gonorrhoeae is growing rapidly.  A 2011 report 
described a N. gonorrhoeae isolate from a female sex worker in Japan, designated H041, with 
high ceftriaxone resistance (Ohnishi et al., 2011).  A second strain isolated in France, F89, was 
also reported to have high resistance to cefixime and ceftriaxone (Unemo et al., 2012).  Given 
that these antibiotics are currently the last remaining options for first-line treatment, there is the 
potential for the development of incurable gonorrhea.    
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1.3 Sites of infection and clinical manifestations 
The most common site of infection is the genital tract.  In women, 50-80% of infections 
are reported as being asymptomatic (Edwards and Apicella, 2004; Moran, 2007).  If symptoms 
are present, they include increased vaginal discharge, dysuria, and uterine bleeding.  In cases 
where initial physical examination appears normal, swabbing of the cervix may reveal purulent 
discharge (Curran et al., 1975).  Around 45% of women with genital tract infection will develop 
ascending infection (Edwards and Apicella, 2004).  This can lead to the development of pelvic 
inflammatory disease (PID), a serious complication of gonorrhea infection in women.  PID is an 
often painful inflammation of the reproductive organs which can lead to tissue scaring, ectopic 
pregnancy, and infertility (Centers for Disease Control, 2014).   
It is estimated that the risk of a male contracting urethral gonorrhea from an infected female 
partner is 20% for a single exposure (Holmes et al., 1970).  Urethral gonorrhea infection in men 
is usually symptomatic.  Infection is reported to be asymptomatic in men in 1-3% of cases 
(Harrison et al., 1979; Hook III and Handsfield, 2008), though in other reports the statistic is 
much higher (Handsfield et al., 1974). Discrepancies in these reports are likely the result of 
sampling bias, differences in the sensitivity of methods used to detect early infection, and 
whether or not the sexual partner through which transmission occurred had symptomatic 
infection.  Studies in male human subjects have demonstrated that there is an incubation period 
between infection and the onset of symptoms of 48-96 hours (Schneider, 1991).  The 
predominate symptoms experienced by men with N. gonorrhoeae infection are urethral discharge 
or dysuria (Hook III and Handsfield, 2008).  It is estimated that prior to the availability of 
antibiotic therapy 95% of infections would resolve spontaneously within six months (Hook III 
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and Handsfield, 2008; Pelouze, 1941).  As in women, serious complications of untreated 
infection can occur, most notably epididymitis (Watson, 1979). 
A less common site of N. gonorrhoeae infection is the pharynx.  In most reported studies, 
pharyngeal infections represent on average less than 10% of total gonorrhea infections, though 
rates tend to be higher in women (10-14%) and men who have sex with men (21%) (Odegaard 
and Gundersen, 1973; Wiesner et al., 1973).  Pharyngeal infections are typically asymptomatic 
and most clear within 12 weeks (Wallin and Siegel, 1979).  Pharyngeal infections that do not 
resolve require higher doses of antibiotics to reliably clear the bacteria than genital tract infection 
and may serve as a reservoir for antibiotic resistant N. gonorrhoeae (Hutt, 1986; Newman et al., 
2007; Weinstock and Workowski, 2009). 
Rectal infection occurs mostly commonly in women and men who have sex with men and, 
like pharyngeal infection, is commonly asymptomatic (Klein, 1977).  Rectal infections in women 
can be the result of contamination with infected cervical secretions or receptive anal intercourse 
(Hunte et al., 2010; Kinghorn and Rashid, 1979). Rectal infections in men are almost always the 
result of receptive rectal intercourse (Hook III and Handsfield, 2008).  Treatment success with 
antibiotic therapy is similar to that observed in cervical and urethral infections (Moran, 1995; 
Schroeter and Reynolds, 1972).   
Disseminated  gonococcal infection occurs in 0.5-3% of patients with untreated gonorrhea 
(Hook III and Handsfield, 2008).  Disseminated infection is more common in women than men 
and some strains of N. gonorrhoeae are more likely to disseminate than others (Holmes et al., 
1971).  The most common symptoms of disseminated infection are tenosynovitis, skin lesions, 
and arthritis.  One study of 49 patients with disseminated infection reported that 61% of patients 
had tenosynovitis, 71% had skin lesions, and 39% had arthritis (O’Brien et al., 1983).  Treatment 
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with an effective antibiotic regimen can usually resolve these symptoms within 48 hours 
(Handsfield, 1976).  
1.4 The immune response to N. gonorrhoeae 
1.4.1 General innate sensing of bacterial pathogens 
Recognition of bacterial pathogens by the immune system involves the cooperation of 
numerous intracellular and extracellular pattern recognition receptors (PRRs), each with 
specificity to particular pathogen-associated molecular patterns (PAMPs).  PRR families include 
the extracellular toll-like receptors (TLR) and c-type lectin receptors (CLR), the intracellular 
NOD-like receptors (NLR), and the secreted peptidoglycan recognition proteins (PGRP). 
The Toll proteins and their role in the immune response to pathogens was first described 
in Drosophila melanogaster (Lemaitre et al., 1996).  To date, 10 functional human TLRs have 
been cloned (Chuang and Ulevitch, 2001, 2000; Du et al., 2000; Rock et al., 1998; Takeuchi et 
al., 1999a) and six of these—TLR1, TLR2, TLR4, TLR5, TLR6 and TLR9—recognize bacterial 
components.  TLR2 can function alone or form heterodimers with TLR1 or TLR6 to recognize 
lipoproteins and lipopeptides of different structural specificities (Morr et al., 2002; Takeuchi et 
al., 2001, 2002).  TLR4, in association with cofactor MD-2, recognizes bacterial 
lipopolysaccharide (LPS) or, in the case of some gram negative bacteria such as N. gonorrhoeae, 
lipooligosaccharide (LOS) (Shimazu et al., 1999).  TLR5 recognizes bacterial flagellin (Hayashi 
et al., 2001) and, finally, TLR9 recognizes unmethylated CpG dinucleotides in bacterial DNA 
(Takeshita et al., 2001).  Activation of these receptors initiates a signaling cascade that leads to 
the production of inflammatory cytokines which trigger a variety of responses including 
recruitment and differentiation of immune cells, antigen presentation, and programmed cell death 
(Akira and Takeda, 2004). 
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The NLR family of proteins is a diverse set of intracellular PRRs that can recognize both 
PAMPs and danger associated molecular patterns.  The NOD1 and NOD2 proteins, for example, 
have both been well-described to recognize specific moieties of bacterial peptidoglycan (Franchi 
et al., 2009).  Many NLRs form complexes known as inflammasomes, which trigger IL-1β 
maturation through the activation of caspase-1 (Martinon et al., 2002). The NLRP3 
inflammasome has been shown to play a role in the innate immune response to bacterial 
infection by recognizing pore-forming toxins (Munoz-Planillo et al., 2009).  The NLRP1 
inflammasome is activated in the presence of muramyl dipeptide (MDP), the peptidoglycan 
ligand for NOD2, and has been shown to complex with NOD2 in response to Bacillus anthrasis 
infection and MDP stimulation (Faustin et al., 2007; Hsu et al., 2008).  Inflammasome 
complexes containing NLR family members NLRC4 and NAIP51 or NAIP5 respond to bacterial 
flagellin and type III secretion systems (Halff et al., 2012; Miao et al., 2006, 2010; Yang et al., 
2013).  Many of the mechanisms that dictate NLR recognition of their ligands and their 
subsequent role in controlling bacterial infections are still unknown. 
Additional proteins involved in the innate immune recognition of bacterial infections 
include the CLRs and PGRPs.  The CLR superfamily is a diverse set of receptors that can be 
soluble proteins or expressed on the surface of many immune cell types, including macrophages 
and dendritic cells.  They can mediate cell-cell interactions and some have been shown to bind 
the saccharide structures of bacterial cell walls (Weis et al., 1998).  Finally, the four mammalian 
PGRPs are intracellular and secreted proteins that recognize bacterial peptidoglycan and also 
have bactericidal activity (Lu et al., 2005).  The mammalian PGRPs are described in more detail 
in section 1.5.4 
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1.4.2 Characterization of the immune response to N. gonorrhoeae 
Gonorrhea infection fails to induce a protective adaptive immune response in the host.  The 
lack of a protective adaptive immune response to N. gonorrhoeae is mediated by a combination 
of mechanisms.  Well-defined mechanisms of gonoccocal immune evasion include suppression 
of T-cell activation and proliferation, poor induction of broadly reactive anti-gonoccocal 
antibodies responses, and antigenic variation of bacterial surface components.  Though the 
development of a protective adaptive immune response is suppressed in N. gonorrhoeae 
infection, inflammatory responses to colonization by the bacteria does occur in many cases, 
likely due to innate immune recognition.  The key components of the immune response to N. 
gonorrhoeae discussed in this section are summarized in Figure 1.1.   
The immune response to N. gonorrhoeae is typically characterized by the influx of 
polymorphonuclear leukocytes (PMNs). The purulent discharge characteristic of symptomatic 
infection in men and some women is the result of PMN influx and shedding of epithelial cells.  
Cytokines known to drive PMN migration to an infection site, IL-17A and IL-23, were found to 
be elevated in the serum of male patients with gonorrhea infection compared to uninfected 
controls (Gagliardi et al., 2011; Laan et al., 1999; Wu et al., 2007).  Experimental infections have 
revealed the presence of IL-8, IL-6, and TNF-α within the urethra (Ramsey et al., 1995).  In 
contrast, local increases of IL-1, IL-6, IL-8, and IL-10 in the genital secretions women with 
gonorrhea infection have not been observed, and serum levels of IL-6 in infected women were 
only modestly elevated (Hedges et al., 1998). Though localized cytokine production was not 
detected in clinical specimens from infected women, in vitro studies with immortalized vaginal 
and cervical epithelial cells report an increase in these cytokines upon stimulation with N. 
gonorrhoeae (Fichorova et al., 2001).  The symptomatic status of the women the clinical samples 
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were analyzed from was not reported, but the lack of local increases in inflammatory cytokines 
may correlate with the asymptomatic gonorrhea infections typically observed in women. 
Subjects with N. gonorrhoeae infection were found to have modestly increased levels of anti-
gonococcal serum IgG in men and IgA1 in women compared to uninfected subjects, and prior 
infection with N. gonorrhoeae did not alter antibody levels in patients with current infection 
(Hedges et al., 1999).  Locally, anti-gonococcal IgG and IgM antibodies do not appear to be 
significantly higher in the cervical mucus of infected and uninfected women.  Levels of local 
anti-gonococcal antibodies in men were not analyzed in this study due to the low number of male 
patients with detectable antibody levels (Hedges et al., 1999).  In vitro, N. gonorrhoeae has an 
ability to kill CEACAM1 expressing B cells and suppress antibody production (Pantelic et al., 
2005).  Recently, it was shown that B cells exposed to N. gonorrhoeae in culture produced non-
specific IgM.  Levels of anti-gonococcal antibodies produced by B cells exposed to N. 
gonorrhoeae were similar to the levels of antibodies against tetanus toxin, an antigen the subjects 
had likely been exposed to previously through vaccination, and Keyhole limpet hemocyanin, a 
control antigen that subjects should not have been exposed to previously (So et al., 2012).  If this 
non-specific induction of antibody production occurs in vivo, the effect is likely to be further 
exacerbated by a lack of T-cell co-stimulation.  N. gonorrhoeae has been shown to suppress the 
activation and proliferation of CD4+ T-cells through several mechanisms in both in vitro cell 
culture systems and in vivo in the mouse model of gonococcal infection. These mechanisms 
include Opa protein binding of CEACAM1 receptor of T-cells, induction of immunosuppressive 
cytokines and cell surface molecules in dendritic cells, and induction of TGF-β production 
through an unknown mechanism (Boulton and Gray-Owen, 2002; Liu et al., 2012; Zhu et al., 
2012).  These studies indicate that there are numerous mechanisms working in concert by which 
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N. gonorrhoeae evades the host adaptive immune system. These data and data demonstrating 
that previously infected patients are at high risk for re-infection with N. gonorrhoeae, including 
re-infection with the same serovar (Fox et al., 1999), indicate a poor humoral immune response 
and lack of a protective adaptive immune response against N. gonorrhoeae. 
1.4.3 The role of N. gonorrhoeae surface molecules in the innate and adaptive immune 
response 
N. gonorrhoeae is highly adapted to its human host, and multiple components of the bacterial 
cell wall interact directly with host receptors and serum factors.  These components include 
gonococcal lipooligosaccharide (LOS) and bacterial proteins such at the Opa, porin, and pilin 
proteins. 
LOS is the predominate glycolipid of the gonococcal outer membrane.  Structurally, LOS is 
similar to lipopolysaccharide (LPS) that is found in the outer membranes of most gram-negative 
bacteria.  Gonococcal LOS consists of the lipid A and core oligosaccharide of LPS, but lacks the 
O-antigen, a glycan polymer side chain attached to the core oligosaccharide (Preston et al., 
1996).  The carbohydrate moieties of N. gonorrhoeae LOS mimic carbohydrates in 
glycosphingolipids of human cells and is considered to be one mechanism of host immune 
evasion (Mandrell and Apicella, 1993).  Antigenic variation of LOS composition can alter the 
ability of N. gonorrhoeae to invade host tissues, maintain serum resistance, and/or confer 
resistance to host antimicrobial peptides (Balthazar et al., 2011; van Putten, 1993).  Variation of 
the carbohydrate composition of the LOS core is mediated through the action of glycosyl 
transferases encoded by the lgt genes (Yang, 1996). The lipid A of LOS in N. gonorrhoeae is 
typically decorated with phosphoethanolamine (PEA) at the 4’ position, which facilitates the 
interaction between outer membrane protein PorB and host complement regulatory factor C4b to 
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enhance serum resistance (Lewis et al., 2013).  PEA decoration also promotes gonococcal 
resistance to host cationic antimicrobial peptides (Lewis et al., 2009).  N. gonorrhoeae which are 
unable to add PEA to lipid A through a deletion of PEA transferase (lptA) have a demonstrated 
fitness defect in both the murine model and the male human challenge model of infection (Hobbs 
et al., 2013).  Other modifications to the lipid A group, such as the addition of phosphoryl 
moieties, result in different potencies in lipid A activation of TLR4 pathways and the induction 
of proinflammatory cytokines (John et al., 2008; Liu et al., 2010). 
The type IV pilus of N. gonorrhoeae is a multi-protein complex that forms a protrusion from 
the outer membrane of the bacteria.  Type IV pili are moderately conserved across gram-negative 
bacteria and play a role in motility, transformation, biofilm formation, and pathogenesis (Craig et 
al., 2004). Gonococcal pili are required for the natural competence of the bacteria and likely 
contribute to the bacteria’s rapid acquisition of antibiotic resistance (Seifert et al., 1990).  A role 
of pilin in pathogenesis is their ability to increase adhesion to host cells (Rudel et al., 1992).  
CD46 has previously been reported as the receptor for Neisseria pili, though another study 
demonstrated that binding efficiencies of piliated N. gonorrhoeae did not correlate with CD46 
expression (Källström et al., 1997; Kirchner et al., 2005).  Though considered to be a virulence 
factor, pilin does not appear to be strictly required for infection, as a N. gonorrhoeae mutant 
unable to express pilin protein due to a deletion in the promoter region of pilE was still able to 
establish infection in male volunteers (unpublished data discussed in(Cohen and Cannon, 1999).  
Antigenic variation of pilin is likely a mechanism of immune system evasion.  Antigenic 
variation results from the recombination of pilE with one of many silent pilS pseudogenes (Haas 
et al., 1992). Pilin variation has been observed in both natural and experimental gonorrhea 
infection (Seifert et al., 1994; Swanson, 1987).       
11 
 
The Opa proteins of N. gonorrhoeae undergo phase variable expression during infection and 
are another example of immune evasion through antigenic variation.  In the N. gonorrhoeae 
strain FA1090, there are 11 Opa loci which express at least 8 antigenically distinct Opa proteins 
(Dempsey et al., 1991). While N. gonorrhoeae not expressing any Opa proteins are able to 
establish infection in the urethra of male volunteers, N. gonorrhoeae isolates recovered from the 
urethra after inoculation with an N. gonorrhoeae isolate with expression of all Opa genes phased 
off increasingly expressed various Opa proteins during the course of infection (Jerse et al., 
1994).  Members of the Opa family proteins of N. gonorrhoeae are thought to play a role in 
bacterial adhesion through interaction with host cell heparin sulfate proteoglycans (HSPG) 
(Grassmé et al., 1997). In addition to avoiding immune recognition through antigenic variation, 
Opa proteins are thought to modify immunologic response through binding of carcinoembryonic 
antigen-related family of adhesion molecules (CEACAM) (Gray-Owen et al., 1997; Virji et al., 
1996a, 1996b).  N. gonorrhoeae binding to the CEACAM1 receptor expressed on primary 
human CD4
+
 T-cells suppresses their activation and proliferation (Boulton and Gray-Owen, 
2002).  The Opa-CEACAM interaction on dendritic cells may affect immune responses to other 
co-infecting pathogens such as HIV (Yu et al., 2013).  As noted in the previous section, this 
interaction presents another mechanism by which N. gonorrhoeae evades a protective adaptive 
host immune response. 
The most abundant outer membrane protein of N. gonorrhoeae is the 34-36 kDa trimeric 
membrane protein designated PorB (Sparling, 2008).  While different strains of N. gonorrhoeae 
carry antigenically distinct alleles of PorB, unlike the other predominate surface molecules 
mentioned above, gonococcal porin does not undergo significant antigenic variation during 
infection and the protein has been studied for its potential as a vaccine antigen (Massari et al., 
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2002; Sandstrom et al., 1982; Zhu et al., 2005).  In addition to its role in allowing small molecule 
transport across the outer membrane, the porin of N. gonorrhoeae has several identified 
functions in the virulence of the bacteria.  Gonococcal porin has been shown to transfer from the 
bacterial outer membrane to host cell membranes and then translocate to the mitochondria of 
immortalized human T cells and epithelial cells. Some researchers have reported that PorB 
translocation to the mitochondria induces host cell apoptosis, which may play a role in the 
epithelial shedding that occurs during infection (Muller, 2000).  Treatment of primary human 
PMNs with isolated porin protein PorB leads to the downregulation of opsonin-dependent cell 
surface receptors (Bjerknes et al., 1995).  Some serotypes of PorB enhance serum resistance by 
binding to factor H, a downregulator of the alternative complement pathway (Ram et al., 1998).  
Thus, gonococcal surface molecules play multiple roles during infection pathogenesis, including 
resistance to host antimicrobial responses, evasion of immune mediated recognition, and 
manipulation of the developing immune response. 
1.4.4 Other immune evasion mechanisms of N. gonorrhoeae 
N. gonorrhoeae has evolved numerous mechanisms to avoid killing by antimicrobial 
responses initiated by the innate immune recognition of the bacteria.  These include resistance to 
complement as described above, resistance to killing by host antimicrobial peptides, and killing 
by the PMNs that infiltrate the site of infection. 
N. gonorrhoeae resistance to killing by PMNs is well-documented (Criss and Seifert, 
2012).  The gonococcal metalloprotease NG1686 and several DNA repair proteins, including 
RecN and RecA, have been shown to mediate resistance to external killing by PMNs and 
resistance to oxidative killing by hydrogen peroxide (Stohl and Seifert, 2006; Stohl et al., 2005, 
2012).  While the Rec proteins are important in the repair of oxidatively damaged DNA, 
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NG1686 appears to promote resistance to oxidative PMN killing through effects on type IV pilus 
production (Stohl et al., 2013).  How the pilus promotes resistance to PMN antimicrobial 
responses is unknown.   In vitro, PMNs have shown the capacity to kill only a subset of N. 
gonorrhoeae,  as 40-70% of bacterial viability is retained in the presence of PMNs following an 
initial killing phase (Criss et al., 2009). The mechanisms by which they are able to survive non-
oxidative host antimicrobial factors has not been well elucidated. 
A partial explanation of the resistance to killing by host PMNs may be resistance to host 
antimicrobial peptides.  Resistance to host antimicrobial peptides is mediated by several 
mechanisms, including LOS structure as noted above as well as via the mtr efflux system (Shafer 
et al., 1998).  In the murine model of infection, mtr mutants of N. gonorrhoeae have a survival 
defect in vivo compared to N. gonorrhoeae with a functional mtr efflux system (Jerse et al., 
2003).  This system has also demonstrated an ability to mediate resistance to hydrophobic 
antimicrobial agents, including progesterone which is found at high concentrations in the female 
genital tract (Hagman et al., 1995).   
1.5 N. gonorrhoeae peptidoglycan properties and interactions with the immune system 
1.5.1 Peptidoglycan fragment release in N. gonorrhoeae 
N. gonorrhoeae, along with Bordetella pertussis, is one of the few pathogenic gram-
negative bacteria known to release biologically relevant quantities of peptidoglycan (PGN) 
monomers during growth and infection (Cookson et al., 1989; Melly et al., 1984).  N. 
gonorrhoeae fail to recover around 15% of their PGN during growth, compared to 1-4% in most 
other gram negative bacteria (Woodhams et al., 2013).  PGN monomers released by N. 
gonorrhoeae (Figure 1.2) contain one GlcNAc-1,6-anhydro-MurNAc disaccharide unit linked to 
a peptide, 80% of which are the L-alanine-D-glutamic acid-meso-diaminopimelic acid tripeptide, 
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with the remaining 20% composed mostly of terminal D-alanine containing tetrapeptide (Sinha 
and Rosenthal, 1980).  In Bordetella pertussis, the bacteria release tetrapeptide-containing 
peptidoglycan monomers that are known as tracheal cytotoxin (TCT) due to their ability to 
damage ciliated epithelial cells (Cookson et al., 1989; Goldman et al., 1982). Monomeric PGN 
fragments from N. gonorrhoeae were later shown to damage the mucosa of human fallopian 
tubes (Chan et al., 2012; Melly et al., 1984).  Purified TCT has been shown to induce expression 
of IL-1β and IL-6 in human monocytes and likely contributes to inflammation during B. 
pertussis infection (Dokter et al., 1994). N. gonorrhoeae PGN has arthropathic properties when 
injected into rats and probably contributes to symptoms of disseminated gonococcal infection 
(Fleming et al., 1986).  The interaction of released PGN with the immune system that trigger 
these inflammatory events and the role the PGN release by N. gonorrhoeae plays in pathogenesis 
in vivo has not been well studied. There are numerous proteins involved in the remodeling of the 
cell wall during growth, and recently several proteins have been implicated in the production and 
release of monomeric PGN in N. gonorrhoeae.  
1.5.2 Peptidoglycan recycling in N. gonorrhoeae  
The cell wall of N. gonorrhoeae is comprised of polymeric PGN consisting of long chains of 
alternating sugars, N-acetylglucosamine and N-acetylmuramic acid. Attached to the N-
acetylmuramic acid is a peptide chain 3-5 amino acids in length. In N. gonorrhoeae and other 
gram-negative bacteria the peptide consists of L-alanine, D-glutamic acid, meso-diaminopimelic 
acid (DAP), and D-alanine. There are several classes of enzymes involved in the remodeling of 
the cell wall during growth.  A model of PGN recycling in N. gonorrhoeae as described in the 
following text is depicted in Figure 1.3 (Adapted from Garcia and Dillard, 2008).   
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Amidases are responsible for cleaving the bond between the L-alanine and the N-
acetylmuramic acid and generating fragments for PGN recycling during growth.  In N. 
gonorrhoeae the periplasmic amidase AmiC cleaves this bond, freeing N-acetylmuramic acid-β-
1,4-N-acetylglucosamine disaccharide from the sacculus.  AmiC is necessary for daughter cell 
separation during division and also functions as one of several N. gonorrhoeae autolysins 
(Garcia and Dillard, 2006). AmpD is a second characterized N. gonorrhoeae amidase that 
cleaves the N-acetylmuramyl-L-alanine bond of cytoplasmic PGN fragments.  Mutation of ampD 
results in a buildup of PGN in the cytoplasm, an increased metabolism of PGN fragments, and a 
reduced release of extracellular PGN fragments (Garcia and Dillard, 2008).    
Endopeptidases and carboxypeptidases cleave the bonds between amino acids on the peptide 
chain, including cross-linkages.  NG1686 is a periplasmic metallopeptidase with both 
endopeptidase and carboxypeptidase activity.  Deletion of ng1686 results in altered colony 
morphology, but not bacterial cell size or cell shape (Stohl et al., 2012).  The precise role of 
NG1686 in PGN recycling and cell wall rebuilding is not well described.  NG1686 also has 
separate roles in N. gonorrhoeae pathogenesis, including resistance to H202 and PMN-mediated 
killing and type IV pilus formation as mentioned in Section 1.4.4 (Stohl et al., 2012, 2013).  
Other proteins with endopeptidase and carboxypeptidase activities are penicillin binding protein 
(PBP) 3 and 4.  Deletion of either PBP in N. gonorrhoeae is tolerated, but deletion of both PBP3 
and PBP4 results in a slowed growth phenotype and altered cell morphology (Stefanova et al., 
2003).  LdcA is a fourth known carboxypeptidase.  LdcA is a cytoplasmic protein responsible for 
removing the terminal D-alanine on the tetrapeptide chain from PGN monomers. 
An additional critical component of PGN recycling in N. gonorrhoeae is the permease 
AmpG, which mediates the uptake of periplasmic PGN fragments and their transport into the 
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cytoplasm.  Deletion mutants for ampG do not have detectable levels of PGN in the cytoplasm, 
and the release of PGN into the culture supernatant by these mutants is increased seven-fold 
(Garcia and Dillard, 2008). 
Additional proteins found within the cytoplasm that further degrade PGN fragments provided 
by AmpG include the N-acetylglucosaminidase NagZ, which produces free N-
acetylglucosamine, and AmhK, which eliminates the 1,6-anhydro bond by phosphorylation of 
the N-acetylmuramic acid.  These proteins are well-described in E. coli and gene homologues 
have been found in N. gonorrhoeae FA1090 whole genome sequencing data (Garcia and Dillard, 
2008).  Mutations in these genes to test the role of their protein products in growth, cell size and 
shape, colony morphology, and PGN release have not been studied.    
Finally, lytic transglycosylases cleave the N-acetylmuramic acid-β-1,4-N-acetylglucosamine 
bond, creating a 1,6-anhydro bond on the muramic acid sugar.  Most N. gonorrhoeae express 
seven lytic transglycosylases.  Two of the seven lytic transglycosylase proteins are encoded on 
the 57-kb gonococcal genetic island (GGI), which is expressed by approximately 80% of all N. 
gonorrhoeae (Ramsey et al., 2011).  All forms of the GGI encode the lytic transglycosylase 
LtgX.  N. gonorrhoeae with ltgX deleted does not secrete detectable levels of DNA during 
growth, suggesting that LtgX is critical for type IV secretion (Kohler et al., 2007).  79% of GGI 
forms encode a second lytic transglycosylase, AtlA (Dillard and Seifert, 2001).  A recombinantly 
expressed AtlA fusion protein demonstrated the ability to digest gonococcal PGN in vitro, 
confirming its activity as a lytic transglycosylase (Kohler et al., 2007).  In vivo, a N. gonorrhoeae 
mutant which contained a point mutation in the putative active site of atlA showed a 500-fold 
reduction in DNA donation (Chan et al., 2012).  Taken together, these data show that one 
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function of some lytic transglycosylases is to produce breaches in the PGN cell wall required for 
the function of type IV secretion machinery. 
In N. gonorrhoeae, the lytic transglycosylase LtgC is important for normal bacterial growth; 
mutation of ltgC was shown to affect gonococcal growth, producing smaller colonies on agar and 
appearing to have a slower growth rate in liquid culture as compared to the isogenic wild type N. 
gonorrhoeae.  Although the ltgC mutant lacks a lytic transglycosylase, it undergoes autolysis 
more readily than its isogenic parental strain.  Finally, electron micrograph analysis revealed that 
ltgC mutants failed to fully separate, suggesting that LtgC acts on PGN specifically at the septum 
of the dividing cell to promote separation (Cloud and Dillard, 2004). 
LtgB and LtgE are currently of unknown function.  Deletion of ltgB in N. gonorrhoeae does 
not affect PGN fragment release or growth.  Interestingly, expression of LtgB in E. coli was able 
to substitute for the function of lambda endolysin and cause cell lysis, indicating that the protein 
does have lytic transglycosylase activity (Kohler, 2005).  A point mutation of ltgE also did not 
affect PGN monomer release, though PGN multimer release appeared slightly elevated (Cloud-
Hansen et al., 2008). 
The two remaining gonococcal lytic transglycosylases, LtgA and LtgD, have been well 
studied and have shown to be responsible for producing the 1,6-anhydro PGN monomers 
released by N. gonorrhoeae.  LtgA is predicted to be a lipoprotein 616 amino acids long and with 
a molecular weight of 67.5kDa.  A deletion mutant of ltgA in N. gonorrhoeae has a 40% 
reduction in the release of PGN monomers compared to wild type (Chan et al., 2012).  LtgD is 
also a predicted lipoprotein, and is 363 amino acids in length with a molecular weight of 
38.5kDa.  A deletion mutant of ltgD showed a 60% reduction in the release of PGN monomers 
(Chan et al., 2012).  These data suggest non-redundant functions for each of these lytic 
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transglycosylases in digesting PGN and producing PGN monomers.  The LtgA and LtgD 
proteins may have different spatial and temporal expression, or they may be responsible for 
digesting PGN fragments of different sizes.  Elimination of PGN monomer release in N. 
gonorrhoeae can be achieved by deleting both ltgA and ltgD. N. gonorrhoeae lacking both LtgA 
and LtgD do not release PGN monomers, but rather PGN multimers that consist of dimers, 
trimers, and other larger fragments. Though N. gonorrhoeae lacking these enzymes fail to release 
recyclable 1,6-anhydromuropeptides, the bacteria do not have a growth defect in culture (Cloud-
Hansen et al., 2008).  It remains unclear what selective pressures are present in the host 
environment to cause N. gonorrhoeae to maintain LtgA and LtgD.   
1.5.3 Other peptidoglycan modifications 
In addition to the proteins involved in the breakdown and re-building of the PGN of the cell 
wall, there are proteins that function to make specific modifications to PGN.  Many bacteria, 
including N. gonorrhoeae, O-acetylate their PGN (Blundell et al., 1980).  The O-acetylation of 
PGN occurs at the C6 carbon of the muramyl residues by the action of an O-acetyltransferase.  In 
N. gonorrhoeae this occurs through a recently identified O-acetyltransferase, PatB (also referred 
to as Ape2), in conjunction with an unknown acetate transport protein (Moynihan and Clarke, 
2010).  N. gonorrhoeae O-acetylate approximately 34-52% of their PGN (Swim et al., 1983). 
PGN modification via O-acetylation is known to increase PGN resistance to lysozyme digestion 
in many pathogenic bacteria, including N. gonorrhoeae (Bera et al., 2006; Dillard and Hackett, 
2005; Moynihan and Clarke, 2011; Rosenthal et al., 1982, 1983).  The PGN O-acetyltransferase 
in Staphylococcus aureus can modulate host cytokine responses to the bacteria by blocking 
lysozyme digestion and subsequently suppressing inflammasome activation. (Shimada et al., 
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2010).  The precise role that O-acetylation of N. gonorrhoeae PGN plays in the immune 
response to infection with the bacteria is unknown. 
A second PGN modification that has been demonstrated in gram-positive bacteria and, more 
recently, in the gram-negative bacteria Helicobacter pylori, is N-deacetylation of the PGN sugars 
(Boneca et al., 2007; Wang et al., 2009).  Like, O-acetylation of PGN, N-deacetylation confers 
resistance to digestion by host lysozyme and suppress host inflammatory immune responses 
(Wang et al., 2010).  No N-deacetylation enzymes have been identified in N. gonorrhoeae and 
thus a role of N-deacetylation in the pathogenesis of infection has not been established.  
1.5.4 Immune system recognition of peptidoglycan 
PGN is a microbe-associated molecular pattern important in the immune recognition of both 
pathogenic and commensal bacteria.  PGN is recognized by several innate immune receptors, 
including the NOD1, NOD2, and the PGRPs.   
In humans, there are four PGRPs, which bind both extracellular and intracellular PGN (Liu et 
al., 2000, 2001; Lu et al., 2005).  In mammals, they are designated PGLYRP1, PGLYRP2, 
PGLYRP3, and PGLYRP4.  While all PGLYRPs have bactericidal activity, PGLYRP2 uniquely 
has amidase activity that contributes to its antimicrobial activity (Gelius et al., 2003; Wang et al., 
2003).  PGLYRP1 is primarily expressed in the granules of neutrophils and eosinophils, 
contributing to their anti-bacterial activity (Cho, 2005).  PGLYRP2 is expressed primarily in the 
liver, where it is then secreted into the blood, but expression also be induced in epithelial cells, 
namely the skin and gastrointestinal tract, through the action of cytokines such as IL-1β and 
TNF-α (Royet et al., 2011; Zhang et al., 2005).  Finally, PGLYRP3 and PGLYRP4 are expressed 
in the skin and mucous membranes (Royet et al., 2011).  Some insect PGRPs have demonstrated 
specificity for DAP-type or Lys-type PGN (Leulier et al., 2003), and the mammalian PGLYRP1 
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preferentially binds multimeric PGN (Liu et al., 2000).  All four PGRPs have been implicated in 
protection against colitis, as mice deficient in any of the four PGRPs have enhanced 
susceptibility to dextran sulfate sodium-induced colitis compared to wild type mice (Saha et al., 
2010).  The likely mechanism for this protection is through innate immune regulation of gut 
commensal bacteria. 
The second set of receptors that detect bacterial peptidoglycan are the including the 
nucleotide-binding oligomerization domain-containing protein 1 (NOD1) and 2 (NOD2) 
proteins. Activation of NOD1 and NOD2 by PGN components D-glutamyl-meso-diaminopimelic 
acid (iE-DAP) or muramyl dipeptide (MDP), respectively, leads to the induction of NF-κB and 
subsequent inflammatory cytokine production (Chamaillard et al., 2003; Girardin et al., 2003a, 
2003b; Inohara, 2003). Due to the requirement of the meso-DAP moiety, which is not present in 
the PGN of gram-positive bacteria, NOD1 is primarily a sensor of gram-negative bacteria.  In 
contrast, NOD2 is a general sensor of all bacteria.  High levels of NOD2 expression is restricted 
to phagocytic cells and some specialized epithelial cells, like Paneth cells of the ileal crypts, 
while NOD1 is more ubiquitously expressed (Inohara et al., 1999; Ogura et al., 2003).  The 
ligand specificity and tissue distribution differences may indicate distinct functions of these 
receptors in bacterial sensing in the host despite similar downstream signaling consequences.  
NOD1 has been shown to play an important role in the host response to Helicobacter pylori 
(Viala et al., 2004). Mutations in NOD2 are associated with development of familial Crohn’s 
disease, an inflammatory bowel disease.  Mutant variants of NOD2 have defective tolerogenic 
responses to commensal flora in the intestine (Kullberg et al., 2008; Petnicki-Ocwieja et al., 
2009).  One mechanism for the defective tolerogenic responses may be due to the NOD2 
mutant’s inability to recruit ATG16L1, a protein involved in the autophagic functions of NOD1 
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and NOD2 (Travassos et al., 2009).   Activation of NOD2 by MDP has been shown to stimulate 
production of antimicrobial peptides including HNP1 and -defensin-2 (Voss et al., 2006; 
Yamamoto-Furusho et al., 2010). NOD2 signaling also plays several roles in coordinating the 
development of adaptive immune responses. For example, NOD2 is known to mediate MHC 
class II antigen-specific CD4+ responses and facilitate polarization of Th2 cells in response to 
those antigens (Cooney et al., 2009; Magalhaes et al., 2008).  Recent studies have characterized 
NOD activation in response to N. gonorrhoeae exposure.  In HEK293 reporter cell lines, N. 
gonorrhoeae culture supernatants were shown to be potent activators of NOD1, but poorly 
activating of NOD2 (Mavrogiorgos et al., 2013).  Our studies present here provide a mechanism 
for this differential activation, as N. gonorrhoeae release large quantities of PGN monomers that 
activate NOD1 but not NOD2.  The role that NOD1 and NOD2 signaling has in N. gonorrhoeae 
infection pathogenesis has not been studied. 
The role of TLR2 in peptidoglycan recognition has not been resolved, as conflicting reports 
exist in the literature regarding the subject. TLR2 was initially identified as a sensor of PGN in 
TLR2
-/-
 mouse macrophages and in fibroblasts transfected with human TLR2 using crude 
preparations of PGN from Staphylococcus species (Takeuchi et al., 1999b; Yoshimura et al., 
1999). However, a report by Travassos et al. demonstrated that highly purified preparations of 
PGN from multiple gram-positive and gram-negative bacterial species were unable to activate 
TLR2 (Travassos et al., 2004).  The purification process involved boiling with SDS to inactivate 
autolysins and remove non-covalently bonded proteins and LPS. Crude PGN preps were then 
treated with α-amylase and trypsin to remove glycogen and covalently bound proteins, 
respectively, followed by a hydrofluoric acid wash of gram-positive PGN to remove secondary 
polysaccharides (such as teichoic acid) covalently bound to the PGN.  Final treatment gram-
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positive and gram-negative PGN involved 8M LiCl and 0.1M EDTA to remove any polypeptidic 
contamination and finally an acetone wash to remove lipoteichoic acids or any traces of LPS 
(Girardin et al., 2003a).   A subsequent paper replicated the purification methods used by 
Travassos et al. using S. aureus PGN and showed that the highly purified PGN could activate 
TLR2 (Dziarski and Gupta, 2005). Some studies show that TLR2 recognizes PGN-associated 
lipoproteins, while another study demonstrates that TLR2 of mouse macrophages recognize 
multimeric PGN from Δlgt S. aureus, which lack lipidated prelipoproteins. (Müller-Anstett et al., 
2010; Travassos et al., 2004).  A contradicting study published around the same time showed the 
polymeric PGN prepared from Δlgt S. aureus did not activate human TLR in a reporter cell line 
(Volz et al., 2010).  There is evidence that TLR2 co-localizes with NOD2, possibly confounding 
the mechanism by which recognition occurs in in vitro systems (Müller-Anstett et al., 2010; 
Watanabe et al., 2004).  Additional studies are needed to understand the role, if any, TLR2 plays 
in PGN recognition and PGN recognition pathways involving NOD1 and NOD2. 
1.6 The murine model of N. gonorrhoeae infection 
There are a limited number of well-characterized models available to study N. gonorrhoeae 
infection in vivo.  While an experimental human challenge model of infection has been 
established, several factors limit the extent of its use for immunologic studies: 1) infection is 
limited to men, 2) studies are expensive and involve a low number of subjects, and 3) ethical 
considerations require rapid antibiotic treatment following the onset of infection (Cohen and 
Cannon, 1999).  Thus, many studies of N. gonorrhoeae infection in vivo rely on an established 
murine model of infection. 
Initial attempts at stable genital colonization of female mice failed, with very few mice 
having recoverable amounts of N. gonorrhoeae following inoculation and N. gonorrhoeae was 
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only recoverable for several days (Johnson et al., 1989; Streeter and Corbeil, 1981).  The 
presence of vaginal flora and vaginal PMNs negatively affect the ability of N. gonorrhoeae to 
colonize the mouse vagina and consequently inoculation during proestrus stage of the estrous 
cycle was more favorable to colonization (Braude, 1982).  In 1990, Taylor-Robinson et al. 
published a report describing the ability of 17β-estradiol-treated germ-free BALB/c mice to 
maintain long-term vaginal colonization with N. gonorrhoeae (Taylor-Robinson et al., 1990).  
These observations lead to the development of a murine model of infection where long-term 
vaginal colonization with N. gonorrhoeae could be achieved with 17β-estradiol treatment and 
regular antibiotic administration to suppress the overgrowth of commensal flora (Jerse, 1999).  
The exact mechanisms by which estradiol promotes susceptibility of mice in colonization with N. 
gonorrhoeae is unknown, but suppressing the influx of PMNs and dampening the inflammatory 
response is thought to play a role (Ralston et al., 2009).  In mice treated with three subcutaneous 
injections of a water-soluble 17β-estradiol spaced 48 hours apart, N. gonorrhoeae can be 
recovered from the genital tract for an average of 10 days (Song et al., 2008).  Colonization time 
can be extended through the use of slow-release estradiol pellets or additional subcutaneous 
injections (Jerse, 1999). 
Access to clean animal housing facilities is critical for utilizing the murine model of N. 
gonorrhoeae infection.  Colonization of the mucosal surfaces with commensal bacteria can 
persist despite a combined oral and intraperitoneal antibiotic regimen.  The presence of enteric 
gram-negative rods and catalase-positive, gram-positive cocci is negatively associated with 
persistence of gonococcal infection in mice (Jerse, 1999; Streeter and Corbeil, 1981).  In my own 
studies, a common commensal contaminate, Staphylococcus xylosus, did not impact the 
establishment of vaginal infection with N. gonorrhoeae, but was associated with accelerated 
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clearance of N. gonorrhoeae (Figure 1.4).  The precise mechanisms that promote accelerated 
clearance of N. gonorrhoeae in the presence of these microorganisms are currently unknown.  
Conversely, the presence of lactobacilli has been correlated with an increase in bacterial recovery 
from mouse vaginal swabs and has been shown to enhance N. gonorrhoeae growth on agar 
(Jerse, 2002; Jerse et al., 2011).  In our studies, mice that test positive for these commensals are 
removed from the study and not considered during data analysis to ensure that data are not 
compromised by variability in commensal colonization.  However, N. gonorrhoeae interaction 
with commensals may be an important area of study, in particular when considering genital 
infection in women and the persistence of infection despite the presence of a diverse vaginal 
microbiota (Newton et al., 2001).  
The choice of mouse strain is another important consideration, as several mouse strain-
dependent differences in susceptibility and immune response to N. gonorrhoeae have been 
observed (Packiam et al., 2010; Streeter and Corbeil, 1981).  For example, while vaginal 
infection in 17β-estradiol treated BALB/c mice typically results in the influx of PMNs, this does 
not occur during infection with C57BL/6 mice (Packiam et al., 2010).  C3H/HeN mice are 
resistant to infection with N. gonorrhoeae, and this resistance is not mediated by an increased 
inflammatory response but by a currently undefined mechanism (Packiam et al., 2010).  Prior to 
the establishment of the murine model of N. gonorrhoeae infection, C3H/HeJ mice were found 
to be more resistant to vaginal infection with N. gonorrhoeae than C3H/HeN mice.  The authors 
concluded the observed resistance of the C3H/HeJ to N. gonorrhoeae colonization was due to 
both high numbers of PMNs in the vaginal mucus and high numbers of recovered gram-negative 
flora (Streeter and Corbeil, 1981).  These data would later be critical in understanding why N. 
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gonorrhoeae is a poor colonizer of the mouse genital tract and informing the protocol for the 
development of an effective mouse model. 
In addition to the characteristic PMN influx during infection, the murine genital tract 
infection model of N. gonorrhoeae infection shares several other characteristics with those 
observed in infection in humans.  Despite an ability to clear N. gonorrhoeae infection, mice do 
not develop a robust humoral immune response and are susceptible to re-infection (Song et al., 
2008).  Cytokines such as IL-6, TNF-α, and IL-17 that have been found to be elevated during 
infection in humans as detailed in section 1.4.2 have also been found to be elevated in mice 
(Feinen et al., 2010; Jerse et al., 2011; Packiam et al., 2010).  Surprisingly, a positive selection 
for Opa-expressing N. gonorrhoeae has also been observed in the mouse model of infection, 
despite the known specificity of Opa for human CEACAM and the lack of a known receptor in 
mice (Cole et al., 2010).  In contrast, there is no known receptor for pilin in mice, and a loss of 
piliation in isolates recovered from mice suggests that piliation does not play a role in the murine 
model of infection (Jerse, 1999). 
There are clear limitations to use of a murine model of infection, including differences in 
physiology, host cell surface receptors, and immune signaling pathways.  For example, mice 
express three additional TLRs, one of which (TLR13) has demonstrated a role in sensing of 
bacterial rRNA (Oldenburg et al., 2012). Mouse NOD1 is able to recognize TCT while human 
NOD1 cannot; ligand differences of NOD2 signaling in mice and humans have not been well 
studied (Magalhaes et al., 2005).  Other differences between mouse and human immune 
responses include distribution of immune cell subsets, expression of immune receptors, 
expression of Ig isotypes, and activation of immune cell types (Mestas and Hughes, 2004). These 
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should be taken into consideration when conducting immunological studies in mice, perhaps 
especially in consideration of N. gonorrhoeae, which does not naturally infect mice. 
Specific to the vaginal mouse model of infection, there are some physiological differences.  
This includes differences in vaginal pH, with mouse vaginal pH being high than human vaginal 
pH, though similar to human cervical pH, where N. gonorrhoeae can establish infection (Muench 
et al., 2009; Singer, 1975).  There is also notably no period of menstrual bleeding in mice, and 
the menstrual cycle in women has been thought to play a role in gonococcal pathogenesis, 
including dissemination of infection (O’Brien et al., 1983).  Finally, as mentioned previously, the 
microflora of the mouse vaginal tract are different than that of women, though this consideration 
must be taken in the context of the infection model, where antibiotics are used to reduce the 
population of commensal species.  The ability of N. gonorrhoeae to access certain critical 
nutrients in the mouse genital tract, such as iron, is unknown; iron sources such as transferrin 
(Tf) and lactoferrin (Lf) are unavailable in mice because the gonococcal Tf and Lf receptors are 
specific to the human ligand (Jerse et al., 2011). 
Thus, careful considerations of the limitations of using a mouse model of N. gonorrhoeae 
must be taken in evaluating experimental results.  The murine model of infection, despite the 
differences mentioned, does mimic many characteristics of infection observed in humans.  The 
model provides a starting point for immunological studies that include vaccine development, and 
can contribute mechanistic data through the use of knockout mice.  An increase in the 
availability of transgenic mice expressing human pilin and Opa receptors would greatly enhance 




1.7 Vaccination against N. gonorrhoeae 
The development of a vaccine against N. gonorrhoeae has been unsuccessful.  Antigenic 
variation of outer membrane proteins and active suppression of the protective adaptive immune 
response, as described in section 1.4, are attributed to these failures.  Still, in a limited number of 
cases, serovar-specific acquired immunity involving the gonoccocal outer membrane protein 
PorB has been reported (Buchanan et al., 1980).  An infection experiment conducted in 
chimpanzees showed the development of short-term resistance to re-infection (Kraus et al., 
1975).  Due to the decline in the use of chimpanzees as experimental models for both ethical and 
financial reasons, these experiments have not been repeated to confirm the result or elucidate the 
mechanisms by which resistance to re-infection occurred.  These cases all represent strain-
specific immunity, a challenge that will need to be overcome to achieve development of a 
broadly acting vaccine. 
To date, two N. gonorrhoeae vaccine candidates have entered clinical trials.  An early trial 
involved a crude whole-cell vaccine formulation.  The vaccine was well tolerated and was able to 
produce antibodies in 90% of the vaccinated group, but the vaccine ultimately failed to protect 
against infection (Greenberg, 1975; Greenberg et al., 1974).  The second vaccine attempt was a 
large clinical trial in Korea and utilized purified N. gonorrhoeae pilin of a single pilus type.  The 
efficacy of this vaccine in women was unable to be assessed, as no women enrolled in the study 
contracted gonorrhea.  There was no protective effect in men, as about equal numbers of men 
who received the vaccine contracted gonorrhea as those who received the placebo (Boslego et 
al., 1991).  Despite the poor efficacy outcome, the vaccine did induce anti-gonococcal pilin 




Recent insights into the type of adaptive immune response important in the development of 
protective immunity to N. gonorrhoeae have been elucidated in the murine model of infection.  
A report by Liu et al. demonstrated that N. gonorrhoeae were able to selectively suppress the 
development of Th1 and Th2 cells through a TGF-β-dependent mechanism.  Importantly, the 
study demonstrated that blockade of the TGF-β signaling pathway using an anti-TGF-β antibody 
was able to redirect the Th response to a Th1/Th2 response in vitro (Liu et al., 2012).  Mice 
treated with anti-TGF-β antibody during infection with N. gonorrhoeae demonstrated accelerated 
clearance of the bacteria, development of anti-gonococcal antibodies, and resistance to 
reinfection (Liu and Russell, 2011).  The use of knockout strains deficient in either Th1 or Th2 
responses showed that the accelerated clearance of the bacteria was due to the Th1 response, but 
resistance to re-infection was dependent on both Th1 and Th2 responses (Liu and Russell, 2011).  
Thus the induction of Th1 and possibly Th2 responses may be a critical component of a vaccine.  
Local administration of microencapsulated IL-12, a proinflammatory cytokine known to activate 
Th1 cells (Macatonia et al., 1995), during N. gonorrhoeae infection in mice caused accelerated 
clearance of the bacteria as well as resistance to re-infection (Liu et al., 2013).  If similar 
responses can be achieved in humans, local administration of proinflammatory cytokines to 
induce a specific Th cell response may be a novel therapeutic approach to treatment of N. 
gonorrhoeae infection, particularly considering the high rate of re-infection in the population 
(Brooks et al., 1978; Hosenfeld et al., 2009). 
The development of a N. gonorrhoeae vaccine is becoming more critical as antibiotic 
resistance becomes wide-spread and the risk of incurable gonorrhea rises.  More research is 
needed to identify antigens and stimulatory molecules that will enhance Th1 and Th2 activation. 
Important to the development of a vaccine are further studies on immune system interaction 
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between N. gonorrhoeae and the host during infection, including mechanisms that mediate 
evasion of a protective adaptive immune response and the induction of inflammatory responses 
that likely contribute to pathogenesis and transmission.  The studies presented here report on the 
roles of N. gonorrhoeae PGN on cytokine production and immune receptor activation, as well as 
the role of lytic transglycosylases LtgA and LtgD in vivo.  We provide a framework for further 






Figure 1.1. Current understanding of the immune response to N. gonorrhoeae infection. 
Upon recognition of N. gonorrhoeae by antigen presenting cells, depicted here as a dendritic cell 
(DC), subsequent cytokine signaling results in the polarization of T-cells to Th17, which produce 
cytokines such as IL-17 and IL-22. In response, epithelial cells produce chemokines in the CXC 
family, which results in the influx of polymorphonuclear leukocytes (PMNs).  N. gonorrhoeae is 
resistant to PMN killing through a combination of resistance to phagocytosis and resistance to 
both oxidative and non-oxidative antimicrobial factors in cases when the bacteria are 
internalized.  Suppression of Th1/Th2 polarization occurs through a TGF-β-dependent 
mechanism.  N. gonorrhoeae can also inhibit the polarization and proliferation of CD4+ T-cells 
through direct interaction with surface CEACAM1 molecules or indirectly through DCs (not 
shown).  This model represents data obtained primarily through in vivo studies using the murine 
model of infection and in vitro studies using immortalized and primary human and mouse cells.  
Cytokines IL-6, IL-17, and IL-23 have been observed to increase locally during N. gonorrhoeae 





Figure 1.2. Structure of the peptidoglycan monomer released by N. gonorrhoeae. 
During growth, N. gonorrhoeae release peptidoglycan monomers comprised of one N-acetyl-
glucosamine (red) linked to one N-acetyl-muramic acid containing a 1,6 anhydro bond (blue).  
Attached to the N-acetyl-muramic acid is a peptide chain consisting of L-alanine, D-glutamic 
acid, meso-diaminopimelic acid and a terminal D-alanine. 80% of PGN monomers released by N. 






Figure 1.3. Peptidoglycan recycling in N. gonorrhoeae. 
PGN fragments are liberated from the sacculus through the action of lytic transglycosylases 
LtgA, LtgD, and amidase AmiC.  Both PGN monomers produced by LtgA and LtgD as well as 
disaccharide fragments are released into the extracellular space by an unknown mechanism.  
PGN fragments that are not released are brought into the cytoplasm through the action of the 
AmpG permease.  Once in the cytoplasm, PGN fragments are broken down for recycling.  LdcA 
is a carboxypeptidase that cleaves the terminal D-alanine from the peptide chain.  AmpD is 
another known amidase of N. gonorrhoeae and cleaves the peptide chain from the N-
acetylglucosamine-N-acetylmuramic acid disaccharide.  NagZ cleaves the bond between these 






Figure 1.4. Persistence of N. gonorrhoeae is significantly reduced in mice colonized with 
commensal species Staphylococcus xylosus. 
The presence of a gram-positive cocci, Staphylococcus xylosus, in the vaginal tract of mice 
causes accelerated clearance of N. gonorrhoeae.  Mice were considered positive for S. xylosus (+ 
S. xylosus) if the organism was recovered from mouse vaginal swabs streaked onto HIA agar for 
at least 8 of the 10 days of the infection study (n = 10).  Mice were considered negative for S. 
xylosus (- S. xylosus) if vaginal swabs indicated less than two days of positive culture (n = 11).  
Median infection persistence of N. gonorrhoeae  was 10 days and 2.5 days for – S. xylosus and + 
S. xylosus, respectively. N. gonorrhoeae strain FA1090 was used in these studies and data shown 
are combined from two separate experiments.  Data was analyzed by GraphPad Prism using a 
Log-Rank Test, * = P < 0.0001   
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Chapter 2  
The role of N. gonorrhoeae peptidoglycan in innate immune signaling 
2.1 Overview 
Neisseria gonorrhoeae releases anhydro peptidoglycan monomers during growth through 
the action of two lytic transglycosylases encoded in the N. gonorrhoeae genome, LtgA and 
LtgD. Because peptidoglycan and peptidoglycan components activate innate immune signaling, 
we hypothesized that the activity of LtgA and LtgD would influence the host responses to 
gonoccocal infection. N. gonorrhoeae lacking LtgA and LtgD caused increased host production 
of inflammatory cytokines IL-1β and TNF-α. Culture supernatants from ΔltgA/ΔltgD N. 
gonorrhoeae, which contain multimeric peptidoglycan fragments rather than monomers, were 
potent activators of host NOD2 signaling when compared to supernatants from the isogenic 
parental N. gonorrhoeae strain. Purified peptidoglycan monomers containing anhydro muramic 
acid produced by LtgA were poor stimulators of NOD2 while peptidoglycan monomers 
containing reducing muramic acid produced by host lysozyme were potent stimulators of NOD2. 
These data indicate that LtgA and LtgD allow N. gonorrhoeae to evade detection by host NOD2.  
2.2 Introduction 
Neisseria gonorrhoeae is an obligate human pathogen responsible for causing the 
sexually transmitted disease gonorrhea. During infection, N. gonorrhoeae triggers localized 
inflammation characterized by the influx of neutrophils. Phagocyte antimicrobial responses and 
host production of antimicrobial agents are initiated following recognition of bacterial 
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components, including LOS, lipoproteins, bacterial DNA, and peptidoglycan (Takeuchi and 
Akira, 2010). The cell wall of N. gonorrhoeae is comprised of polymeric peptidoglycan (PGN) 
consisting of long chains of alternating sugars, N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc). Attached to the MurNAc is a peptide chain 3-5 amino acids in 
length. In N. gonorrhoeae and other gram-negative bacteria the peptide consists of L-alanine, D-
glutamic acid, meso-diaminopimelic acid (DAP), and D-alanine. Amidases, endopeptidases, and 
lytic transglycosylases act on PGN to mediate bacterial cell wall remodeling during growth and 
replication. 
Though cell wall remodeling typically leads to the release of some PGN-derived 
products, these are usually efficiently reutilized by the bacteria. Unlike most pathogenic gram-
negative bacteria, N. gonorrhoeae and Bordetella pertussis are known to release intact PGN 
monomers in excess of the capacity of the bacteria to reclaim the material and in sufficient 
quantities to induce significant inflammatory responses in host tissues (Goldman et al., 1982). 
PGN monomers released by N. gonorrhoeae contain one GlcNAc-1,6-anhydro-MurNAc 
disaccharide unit linked to the L-alanine-D-glutamic acid-meso-diaminopimelic acid tripeptide 
(80%) and tetrapeptide bearing an additional terminal D-alanine (20%) (Sinha and Rosenthal, 
1980). The tetrapeptide PGN monomers, also known as tracheal cytotoxin (TCT), were first 
isolated from B. pertussis as the causative agent of ciliated cell death in host airways (Goldman 
et al., 1982). Monomeric PGN fragments from N. gonorrhoeae were later shown to damage the 
mucosa of human fallopian tubes (Melly et al., 1984). The N. gonorrhoeae genome encodes 
seven lytic transglycosylases capable of liberating PGN from N. gonorrhoeae sacculi, but only 
LtgA and LtgD are responsible for production of 1,6-anhydro-MurNAc-containing PGN 
monomer released by N. gonorrhoeae during growth in culture (Cloud-Hansen et al., 2008). 
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Instead of releasing monomeric 1,6-anhydro-MurNAc-containing PGN monomers, N. 
gonorrhoeae lacking both ltgA and ltgD release a variety of multimeric PGN fragments (Cloud-
Hansen et al., 2008). The role PGN monomer production by LtgA and LtgD plays in the host 
response to N. gonorrhoeae infection has not been elucidated.  
PGN acts as a microbe associated molecular pattern (MAMP) that is recognized by the 
innate immune system in response to bacterial infections and commensal species. PGN 
components are recognized by several host receptors, including the nucleotide-binding 
oligomerization domain-containing protein 1 (NOD1) and 2 (NOD2) proteins. Activation of 
NOD1 and NOD2 by PGN components D-glutamyl-meso-diaminopimelic acid (iE-DAP) or 
muramyl dipeptide (MDP), respectively, leads to the induction of NF-κB and subsequent 
inflammatory cytokine production (Chamaillard et al., 2003; Girardin et al., 2003a, 2003b; 
Inohara, 2003). NOD2 has been implicated in Crohn’s disease and mutations in the protein have 
defective tolerogenic responses to commensal flora in the intestine (Kullberg et al., 2008). 
Recently, N. gonorrhoeae culture supernatant, which contains secreted 1,6-anhydro-MurNAc-
containing PGN monomers, was shown to more robustly activate NOD1, while the PGN 
polymer-containing lysates were found to stimulate both NOD1 and NOD2 equally 
(Mavrogiorgos et al., 2013). In addition to being recognized intracellularly by NOD1 and NOD2, 
extracellular multimeric PGN from gram-negative bacteria activates host Toll-like receptor 2 
(TLR2), though some studies now suggest that TLR2 recognizes PGN-associated lipoproteins 
rather than multimeric PGN itself (Travassos et al., 2004). Recognition of bacterial PGN via 
these systems allows the host to initiate antimicrobial responses (Gold et al., 1985; Greenblatt et 
al., 1978).  
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In this study, we sought to assess the role of N. gonorrhoeae LtgA and LtgD-mediated 
PGN monomer release on the innate immune responses as well as the specific immune receptor 
responses to N. gonorrhoeae PGN monomers. Here we showed that N. gonorrhoeae lacking 
LtgA and LtgD induced production of significantly more inflammatory cytokines and greater 
activation of host TLR2 and NOD2 signaling when compared to wild type N. gonorrhoeae. The 
difference in NOD2 signaling was due to the inability of host NOD2 to recognize 1,6-anhydro-
MurNAc-containing PGN monomers produced by the LtgA and LtgD proteins. In contrast, PGN 
monomers produced by the action of host lysozyme on PGN multimers lack the 1,6-anhydro 
bond and were potent activators of NOD2. Together, these data show that the LtgA and LtgD 
suppress host NOD2-mediated inflammatory cytokine signaling by converting multimeric PGN 
fragments generated during bacterial growth to 1,6-anhydro-MurNAc-containing PGN 
monomers. 
2.3 Materials and Methods 
2.3.1 Generation of N. gonorrhoeae ltgA/ltgD mutant 
N. gonorrhoeae strain FA1090 ΔltgA/ΔltgD was generated as described previously 
(Cloud and Dillard, 2002; Cloud-Hansen et al., 2008). Whole genome sequencing of FA1090 
ΔltgA/ΔltgD confirmed that the entire coding region of ltgD was deleted while the ltgA gene was 
disrupted by deletion of the last 1420 bp of the 1850 bp ltgA coding region and insertion of the 
ermC gene conferring erythromycin resistance.  A second construction of the ΔltgA/ΔltgD 
mutant, FA1090 ΔltgA/ΔltgD (KK) is described in Appendix 1. 
2.3.2 Generation of N. gonorrhoeae culture supernatants 
N. gonorrhoeae strains were grown overnight on GCB agar plates.  The bacteria were 
suspended at OD600 = 0.2 in 10 mL Graver Wade media (Wade and Graver, 2007) in 125 mL 
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sterile flasks and grown for 4.5h at 37°C and 5% CO2 in a shaker incubator. Bacteria were 
removed by collection of culture supernatant after centrifugation followed by filtration through a 
sterile 0.2μm syringe filter.  The viability (CFU/mL) was monitored by plating three dilutions of 
a sample from each strain on GCB agar plates at the beginning and end of each incubation and 
counting colonies after 48h.  Culture supernatants were generated on multiple days to account for 
day-to-day variability. 
2.3.3 Culture supernatants 
N. gonorrhoeae strains were grown overnight on GCB agar plates, suspended at OD600 = 
0.2 in 10 mL Graver Wade media, and grown for 4.5h at 37°C and 5% CO2 in a shaker 
incubator. The bacterial density (CFU/mL) was monitored by counting colonies on plated 
dilutions of the bacterial suspensions made before and after the growth period. Culture 
supernatants were generated by centrifugation followed by filtration through a sterile 0.2μm filter 
on at least three separate days to account for day-to-day variability. 
2.3.4 Reporter cell lines 
Commercially available HEK 293 cells stably transfected with the NOD1, NOD2, or 
TLR2 receptor and an alkaline phosphatase reporter (Invivogen) were stimulated with FA1090 
wildtype, ΔlgtD or ΔltgA/ΔltgD conditioned media or isolated PGN.  Cells were plated in 96-
well plates according to manufacture specification and incubated with samples at 37°C, 5% CO2 
overnight.  Receptor response was quantified using a colorimetric alkaline phosphotase assay. 
2.3.5 Cell Culture and Cytokine Analysis 
THP1 cells were grown in suspension in RPMI 1640 containing 10% fetal bovine serum, 
50 U/mL penicillin, and 50 g/mL streptomycin. Human dendritic cells were generated by 
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culture of CD34+ cells from peripheral blood in AIM V medium with 10% human AB serum 
and Stem Cell Factor (SCF 50 ng/mL), Flt3L (100 ng/mL), GM-CSF(800 U/mL) and IL-4(500 
U/mL) for 14 days.  Blood was obtained from subjects enrolled in a UNC IRB approved study 
(Study #05-2860) after obtaining informed consent. The cells were cultured and de-identified 
prior to transfer to our laboratory for exposure to N. gonorrhoeae culture supernatant (Zhu et al., 
2012). The use of these de-identified cells was reviewed by the UNC Office of Human Research 
Ethics (Study #12-0024) and was determined not to require further IRB approval because the 
study did not constitute human subjects research as defined under federal regulations [45 CFR 
46.102 (d or f) and 21 CFR 56.102(c)(e)(l)]. THP1 cells were plated at 1 x 10
6
 cells/mL and 
exposed to either N. gonorrhoeae culture supernatants or live N. gonorrhoeae for 4h. In the cases 
in which cells were exposed to live bacteria, antibiotic-free RPMI 1640 containing 10% fetal 
bovine serum only was used. TNF-α and IL-1β cytokine analyses on cell supernatants were done 
using ELISA (BD Biosciences).  
2.3.6 Purification of N. gonorrhoeae peptidoglycan fragments 
Peptidoglycan fragments from N. gonorrhoeae were isolated by the Dillard Lab as 
described previously(Cloud-Hansen et al., 2008).  Briefly, fragments were obtained from PGN 
sacculi isolated from ΔpacA ΔmsbB N. gonorrhoeae. PGN fragments containing the 1,6-anhydro 
bond were obtained by digesting whole N. gonorrhoeae PGN with soluble LtgA for 15min or 4h 
to obtain, multimers and dimers, over overnight at 37°C  to obtain monomers. Monomeric 
fragments containing the reducing bond were obtained by digesting whole PGN with human 
neutrophil lysozyme overnight at 37°C.  Purification of soluble multimer, dimer, and monomer 
fragments was performed on tandem 350-ml Bio-Gel P6 and Bio-Gel P30 size exclusion 
columns and tripeptide and tetrapeptide monomers were further purified by HPLC. 
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Peptidoglycan structures were confirmed by mass spectroscopy.  Peptidoglycan fragments were 
quantified using a Fluoraldehyde OPA (o-phthalaldehyde) Reagent solution (Thermo Scientific 
Pierce).  Fluorescent units correlate with the number of primary amines, a single primary amine 
which is present on the diaminopimelic acid of a monomeric PGN unit.  Peptidoglycan solutions 
were standardized for experimental use using isoleucine and phenylalanine. 
2.4 Results 
2.4.1 The N. gonorrhoeae LtgA and LtgD proteins play a role in suppressing the 
inflammatory cytokine production. 
In order to assess the effect of N. gonorrhoeae LtgA and LtgD on host cell cytokine 
production, PMA-stimulated THP1 cells were exposed to wild type N. gonorrhoeae strain 
FA1090 or an isogenic mutant with deletions of the ltgA and ltgD genes (FA1090 ΔltgA/ΔltgD) 
and the accumulation of IL-1β and TNF-α in the cell culture supernatants was measured. Cells 
exposed to FA1090 ΔltgA/ΔltgD secreted significantly greater quantities of both cytokines than 
those exposed to the isogenic parent (Figure 2.1A). Culture supernatants from FA1090 
ΔltgA/ΔltgD also elicited greater inflammatory cytokine production from THP1 cells and 
primary human dendritic cells than culture supernatant from the parental strain (Figure 2.1B and 
2.1C). To ensure the enhanced induction of host cell cytokine production by bacteria or bacterial 
culture supernatants was not due to differences in the growth of wild type and ΔltgA/ΔltgD 
FA1090 strains, the optical density of the cultures was monitored over a four-hour growth period 
and no significant difference in the optical density was observed between strains (Figure 2.1D). 
Profiling of PGN fragment release from wild type and ΔltgA/ΔltgD FA1090 by size exclusion 
chromatography of culture supernatant after metabolic labeling of the bacteria with [6-
3H]glucosamine revealed that ΔltgA/ΔltgD FA1090 released dimeric and multimeric PGN while 
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wild type FA1090 released primarily monomeric PGN with a small peak of dimeric PGN (Figure 
2.1E), as previously described for N. gonorrhoeae strain MS11 (Cloud-Hansen et al., 2008). 
Overall, these data demonstrate that culture supernatants containing multimeric PGN fragments 
released from ΔltgA/ΔltgD N. gonorrhoeae have enhanced capacity to elicit host inflammatory 
cytokine production.  
2.4.2 The N. gonorrhoeae LtgA and LtgD proteins modulate NOD2 and TLR2 receptor 
signaling.  
To identify immune receptors involved in increased host cytokine response to FA1090 
ΔltgA/ΔltgD, commercially available HEK293 reporter cells stably transfected with NOD1, 
NOD2, TLR2, TLR4, or TLR9 were used to assess innate immune receptor activation by culture 
supernatants from wild type or ΔltgA/ΔltgD N. gonorrhoeae. FA1090 ΔltgA/ΔltgD culture 
supernatants consistently resulted in greater NOD2 activation (Figure 2.2A), with a 13-fold 
increase in activation over basal levels, compared to a 5-fold increase for the wild type. 
Similarly, culture supernatants from FA1090 ΔltgA/ΔltgD induced a 7.5-fold activation of 
reporter activity in TLR2-expressing reporter cell lines, compared to the 4.5-fold increase caused 
by wild type culture supernatants (Figure 2.2B). In contrast, NOD1-, TLR4-, and TLR9-
expressing reporter cells demonstrated equivalent reporter activation after exposure to either 
FA1090 or FA1090 ΔltgA/ΔltgD culture supernatants (Figure 2.2C, 2.2D, and 2.2E). HEK293 
cells carrying only the reporter demonstrated there was no reporter activation difference between 
FA1090 and FA1090 ΔltgA/ΔltgD culture supernatants due to stimulation of endogenous innate 




2.4.3 Monomeric and dimeric peptidoglycan fragments from N. gonorrhoeae differentially 
stimulate innate immune receptors. 
Because culture supernatants from ΔltgA/ΔltgD N. gonorrhoeae contain decreased levels 
of anhydro PGN monomers and increased levels of multimeric PGN (Figure 2.1G), we sought to 
test whether polymeric N. gonorrhoeae PGN exhibited a differential capacity to stimulate NOD2 
and TLR2 when compared to monomeric PGN released through the activity of LtgA. Soluble 
monomeric and multimeric PGN was generated by complete or partial digestion of N. 
gonorrhoeae sacculi with recombinant LtgA. The quantity of PGN in the preparations was 
assessed by quantitating the free amine group of the meso-DAP and equivalent quantities of DAP 
mass were used to test the ability of monomeric and multimeric PGN to stimulate NOD1, NOD2, 
and TLR2 using HEK293 reporter cell lines. Both monomeric PGN and multimeric PGN 
induced significant NOD1 activation; monomeric PGN induced an 8-fold activation of alkaline 
phosphatase activity above basal levels and equivalent quantities of multimeric PGN induced 
2.7-fold levels of reporter activation (Figure 2.3A). In contrast, incubation of the cells with 
multimeric PGN induced significant activation of NOD2 (3.3-fold induction) while incubation 
with monomeric PGN did not (1.3-fold induction, p>0.05) (Figure 2.3B).  
The purified PGN fragments showed modest activation of TLR2 above baseline with no 
significant difference between monomeric and multimeric PGN (Figure 2.3C). The stimulation 
observed in NOD1-, NOD2-, and TLR2-expressing cells was not observed in cells expressing 
only the reporter construct (Figure 2.3D) Because we did not observe differences between the 
different PGN species’ capacity to stimulate TLR2, we sought to determine if other known 
activators of TLR2 were differentially present in the culture supernatants of FA1090 and 
FA1090 ΔltgA/ΔltgD. Immunoblot analysis with antibodies directed against the N. gonorrhoeae 
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PorB and the lipoprotein Lip, both known to activate TLR2, showed that both proteins were in 
higher abundance in culture supernatants from FA1090 ΔltgA/ΔltgD than those from the parental 
FA1090 strain (Figure 2.3E) (Fisette et al., 2003; Massari et al., 2009). Overall, these data 
indicate that isolated gonococcal PGN, in either multimeric or 1,6-anhydro-MurNAc-containing 
monomeric form, is a weak stimulator of TLR2 and that LtgA and LtgD may modulate host 
TLR2 signaling by reducing release of TLR2 activating outer-membrane proteins.  
2.4.4 N. gonorrhoeae LtgA-generated PGN monomers have diminished capacity to activate 
NOD2 compared to host lysozyme-generated PGN monomers. 
Because NOD2 can be stimulated by monomeric MDP, the increased NOD2 signaling 
induced by multimeric PGN was unlikely to be attributable simply to the multimeric structure of 
the PGN. Instead, we hypothesized that reducing MurNAc-containing PGN monomers produced 
by the action of host lysozyme on multimeric PGN could stimulate NOD2 while 1,6-anhydro-
MurNAc-containing monomeric PGN generated by LtgA could not (Figure 2.4A). To test this, 
we generated PGN monomers from N. gonorrhoeae PGN using either recombinant LtgA or 
human neutrophil lysozyme. Structures of the resulting monomers were confirmed by mass 
spectrometry and show PGN monomers with peptide chain lengths of two to five amino acids 
(data not shown). Isolated monomeric fragments were tested for activation of NOD1 and NOD2 
(Figure 2.4B and 2.4C). Because the PGN monomers should contain equivalent quantities of the 
NOD1-stimulating iE-DAP ligand, irrespective of the enzyme used to cleave the GlcNAc and 
MurNAc bond, we did not expect to observe a difference in NOD1 activation between monomer 
preparations. As expected, these PGN monomers stimulated NOD1 receptor activation with 
equal potency (Figure 2.4B). However, in NOD2-expressing reporter cells, lysozyme-digested 
PGN monomers were more potent activators of NOD2 signaling when compared to LtgA-
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digested PGN monomers. To ensure that the reduced NOD2 signaling was the result of the 
presence of the 1,6-anhydro-MurNAc  moiety of the monomer and not variability in amino acid 
chain lengths within the mixture, tripeptide- and tetrapeptide-containing, 1,6-anhydro-muramyl 
or reducing-muramyl PGN monomers were isolated by HPLC and tested using NOD1- or 
NOD2- expressing reporter cell lines. As expected, there was no difference in NOD1 activation 
between the 1,6-anhydro- or reducing-MurNAc PGN tripeptide at either concentration tested. 
The 1,6-anhydro- and reducing-MurNAc monomers containing tetrapeptide induced little to no 
activation of NOD1 (Figure 2.4D). 1,6-anhydro-MurNAc-containing PGN tripeptide monomer, 
the predominant PGN monomer released by N. gonorrhoeae, did not activate NOD2 above basal 
levels. In contrast, the reducing-MurNAc tripeptide monomer produced by human lysozyme 
induced a 10.8-fold (8 uM) and 3.9-fold (800 nM) increase in NOD2 activation (Figure 2.4E). 
Additionally, 1,6-anhydro-MurNAc-containing PGN tetrapeptide (TCT) failed to activate 
NOD2, while the reducing-MurNAc-containing PGN tetrapeptide (8 uM) also activated NOD2, a 
8.2-fold increase over basal levels. These data demonstrate that PGN monomers released by N. 
gonorrhoeae lytic transglycosylases LtgA and LtgD fail to activate host cell NOD2 because the 
1,6-anhydro-MurNAc structure in the monomer is not recognized by NOD2.  
2.5 Discussion 
The role of PGN monomer production and release by N. gonorrhoeae in host immune 
recognition of the bacteria is not well studied.  Previous studies have demonstrated that N. 
gonorrhoeae releases PAMPs that preferentially induce NOD1 activation over NOD2 activation 
(Mavrogiorgos et al., 2013). Our data show that an important factor in directing the host innate 
immune response to N. gonorrhoeae are the LtgA and LtgD lytic transglycosylases, which act in 
the production of 1,6-anhydro monomeric PGN fragments (Summarized in Figure 2.5).  
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In agreement with previously published reports, our studies demonstrate that endogenous 
PGN monomers produced by N. gonorrhoeae LtgA and LtgD are potent activators of NOD1 but 
not NOD2.  This activation of NOD1, but not NOD2, by monomeric anhydro PGN agree with 
previous reports that TCT does not activate human NOD2 (Magalhaes et al., 2005) but that PGN 
structures terminating with iE-DAP in the peptide chain can activate NOD1 (Girardin et al., 
2003c). Our data in NOD2-expressing reporter cells show that the multimeric forms of PGN are 
more potent than the monomeric form.  The capacity of multimeric forms of PGN to stimulate 
NOD2 may in part be due to digestion of these PGN fragments by host cellular lysozyme, which 
has previously been shown to facilitate NOD2 recognition of Streptococcus pneumonia (Davis et 
al., 2011).  Lysozyme generated PGN monomers are more potent activators of NOD2 than the 
LtgA 1,6-anhydro product regardless of the amino acid chain length.  A synthetic addition of 
UDP to the hydroxyl group on the muramic acid has been previously shown to enhance NOD2 
activation to a synthetic meso-DAP containing muramyl tripeptide, demonstrating the 
importance of the muramic acid moiety of PGN in NOD2 mediated recognition of these PAMPs 
(Girardin et al., 2003c).  We now demonstrate that modification to the muramic acid sugar by a 
native bacterial enzyme can alter NOD2 signaling in response to the bacteria.  In this case, the 
formation of PGN monomers with a 1,6-anhydro bond by LtgA reduces stimulation of NOD2, 
which is otherwise triggered by secreted multimeric PGN fragments generated by bacterial 
growth.  Together, these data help explain why an increase in NOD2, but NOD1, signaling is 
seen in response to culture supernatants from FA1090 ΔltgA/ΔltgD, which produce large PGN 
fragments that can be processed by native lysozyme to produce the NOD2-stimulating, reducing 
PGN monomer. These data present an explanation for a recently reported observation that N. 
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gonorrhoeae bacterial culture supernatants induced weak NOD2 activation when compared to 
whole bacteria lysates (Mavrogiorgos et al., 2013).   
In addition to inducing more robust host NOD2 signaling, the deletion of ltgA and ltgD in 
N. gonorrhoeae leads to increased TLR2 signaling in response to the bacteria. Previous studies 
have implicated TLR2 in host response to PGN while some studies suggest that TLR2 has no 
direct ability to recognize PGN (Li et al., 2010; Travassos et al., 2004).  It has been proposed that 
TLR2 responds to multimeric PGN but not monomeric PGN (Müller-Anstett et al., 2010).  
Others have proposed that PGN signaling via TLR2 is the result of contaminates, such as 
lipoproteins or teichoic acids (Volz et al., 2010).  Our results do not show a significant difference 
in the activation of TLR2 between multimeric PGN, dimeric PGN, or monomeric PGN, though 
all three PGN species only weakly activate TLR2. The increased capacity to induce TLR2 
activation by culture supernatants from the ΔltgA/ΔltgD mutant is accompanied by increased 
quantities of known TLR2 stimulating proteins from N. gonorrhoeae, PorB and Lip (Massari et 
al., 2002).  We hypothesize that release of these TLR2-activating polypeptides accompanies 
release of larger PGN multimers that are not processed into 1,6-anhydro-MurNAc-containing 
PGN monomers in this strain.   
Thus we present here a specific modification of PGN by N. gonorrhoeae lytic 
transglycosylases LtgA and LtgD suppresses the response of the innate immune receptor NOD2, 
in contrast to the modification of PGN generated during break-down by host lysozyme.  
Interestingly, peptidoglycan modification via O-acetylation has previously been shown to 
increase PGN resistance to lysozyme digestion in many pathogenic bacteria, including N. 
gonorrhoeae (Bera et al., 2006; Dillard and Hackett, 2005; Moynihan and Clarke, 2011; 
Rosenthal et al., 1982, 1983).  The PGN O-acetyltransferase in Staphylococcus aureus has been 
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shown to modulate host cytokine responses to the bacteria by modulation of signaling by the 
innate immune receptors NOD2 and NLRP3 (Shimada et al., 2010). Together, these data 
combined with our reported findings suggest that the N. gonorrhoeae maintains multiple 
mechanisms to suppress host NOD2 signaling. Interestingly, while suppressing host NOD2 
signaling, N. gonorrhoeae secretes large quantities of NOD1 activating ligand, suggesting the 
two receptors play non-redundant roles in gonococcal pathogenesis. This presents a challenge to 
study N. gonorrhoeae pathogenesis using the murine model of N. gonorrhoeae due to the 
differences between mouse and human NOD1 ligand specificity (Magalhaes et al., 2005).  It is 
yet to be determined if the ability of these PGN fragments to avoid NOD2 signaling while 
simultaneously stimulating NOD1 is beneficial to the establishment, the persistence and/or 
transmission of infection.  Activation of NOD2 by MDP has been shown to stimulate production 
of antimicrobial peptides like HNP1 and -defensin-2 (Voss et al., 2006; Yamamoto-Furusho et 
al., 2010).  NOD2 has been shown to play a role in adaptive immune responses that are known to 
be weak or absent in humans infected with N. gonorrhoeae (Fox et al., 1999).  For example, 
NOD2 is known to mediate MHC class II antigen-specific CD4+ responses and facilitate 
polarization of Th2 cells in response to those antigens (Cooney et al., 2009; Magalhaes et al., 
2008).  In the mouse model of N. gonorrhoeae, induction of Th2 responses have been shown to 
be critical in the clearance of N. gonorrhoeae (Liu and Russell, 2011; Liu et al., 2012). 
Suppression of NOD2 activation by N. gonorrhoeae LtgA and LtgD modified PGN may 
therefore may be mechanisms to suppress both innate and adaptive immune responses to this 
pathogen, allowing for the persistence of infection and transmission of the disease. Given the  
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role of NOD2 in host defense and immune response, the modification of released PGN fragments 






                                                                                                                
IL-1β (top) and TNF-α (bottom) production was measured in (A) PMA-stimulated THP1 cells 
challenged with live N. gonorrhoeae (Multiplicity of Infection = 0.1), THP1 cells (B) or human 
dendritic cells (C) exposed to N. gonorrhoeae culture supernatants from N. gonorrhoeae grown 
in Graver-Wade medium as described in the Experimental Procedures. Secreted cytokines were 
below the level of detection (15.6 pg/ml for IL-1 and 78 pg/ml for TNF-) for untreated cells or 
cells treated with Graver-Wade medium. (D) Optical density of indicated N. gonorrhoeae strain 
cultures at the indicated time points (E) Size exclusion chromatography profiles of PGN 
fragments released from FA1090 or FA1090 ΔltgA/ΔltgD after labeling of PGN pool with [6-
3
H]glucosamine. Data points are plotted as mean +/- S.E.M. from triplicate samples. Plots are 
representative of repeated experiments (for A-B, n>3 for C-E, n=2) Significance was determined 
using Student’s T-test with the determined p-value indicated. 
Figure 2.1. Deletion of the ltgA and ltgD genes in N. gonorrhoeae results in increased 



















                                                                                                                
(A) NOD2, (B) TLR2, (C) NOD1, (D) TLR4, (E) TLR9, and (F) Null HEK293-Blue™ cells 
were treated with culture supernatants from the indicated N. gonorrhoeae strains and reporter 
SEAP activity was measured as described in the Experimental Procedures. Data is expressed as 
fold activation over the basal levels of alkaline phosphatase production from cells treated with 
Graver-Wade Medium for each independent experiment. Data shown represent mean values +/- 
S.E.M. from cells treated with two preparations of culture supernatants and experiments were 
repeated at least twice. Significance was determined using ANOVA with Bonferroni posttest for 
multiple comparisons, a corrected p-value < 0.05 was considered significant. 
  
Figure 2.2. Culture supernatants from N. gonorrhoeae lacking ltgA and ltgD genes exhibit 


















                                                                       
Monomeric PGN was prepared using recombinant LtgA (as described in Experimental 
Procedures) and receptor activation was compared to multimeric PGN using reporter cell lines 
described in Figure 2.2: (A) NOD1, (B) NOD2, (C) TLR2, and (D) Null1 HEK293-Blue™ cells. 
(E) Culture supernatants from the indicated strains of N. gonorrhoeae were analyzed by 
immunoblot using antibodies directed against PorB (top) and lipoprotein Lip (bottom). (A-D) 
Data shown represent mean values +/- S.E.M. from cells treated with two preparations of culture 
supernatants and experiments were repeated at least twice. Statistical analysis was done using 
one-way ANOVA with Bonferroni posttest for multiple comparisons and indicates comparison 
to basal activation (* p< 0.05; *** p<0.001). The dashed line demonstrates the normalized basal 
SEAP activity. 
  
Figure 2.3. Multimeric PGN and Monomeric PGN released by N. gonorrhoeae LtgA                   




















              
               
(A) The structure of 1,6-anhydro-MurNAc-containing PGN monomers predominantly released 
by LtgA (left) and reducing-MurNAc-containing PGN monomers predominantly released by 
lysozyme (right). (B) NOD1- and (C) NOD2-expressing reporter cells were treated with the 
indicated LtgA- or lysozyme-liberated PGN monomers at the indicated concentrations. 
Monomers contained a mixture of PGN monomer species as described. The indicated PGN 
monomer species were further isolated using HPLC and the capacity of each to stimulate NOD1 
(D) and NOD2 (E) reporter cells was assessed. Data shown are representative of at least two 
experiments from at least two independent preparations of PGN monomers. (B-E) Data shown 
represent mean values +/- S.E.M. from cells treated with two preparations of culture supernatants 
and experiments were repeated at least twice. Statistical analysis was done using one-way 
ANOVA with Bonferroni posttest for multiple comparisons (**** P < 0.0001). The dashed line 
demonstrates the normalized basal SEAP activity 





Figure 2.5. Summary figure showing N. gonorrhoeae evasion of NOD2 signaling through 
the production of 1,6-anhydro PGN monomers by LtgA and LtgD. 
Wild type N. gonorrhoeae release large quantities of cytotoxic 1,6-anhydro PGN monomers 
during growth.  These monomers are produced through the action of lytic transglycosylases LtgA 
and LtgD.  The addition of the 1,6-anhydro bond on the muramic acid sugar by LtgA and LtgD 
results in PGN fragments that cannot be recognized by NOD2. When the ltgA and ltgD genes are 
deleted, N. gonorrhoeae release PGN multimers.  These multimers are then subject to digestion 
by host lysozyme and detection by NOD2.  
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Chapter 3  




Neisseria gonorrhoeae releases 1,6-anhydro peptidoglycan monomers during growth that 
are the product of two lytic transglycosylases, LtgA and LtgD.  N. gonorrhoeae lacking LtgA 
and LtgD do not release peptidoglycan monomers, but rather large, multimeric peptidoglycan 
fragments.  We sought to determine the role of released peptidoglycan monomers in the 
pathogenesis of gonorrhea infection in vivo in a murine model of infection using a N. 
gonorrhoeae mutant with the ltgA and ltgD genes deleted.  Secondly, as we have previously 
shown that LtgA and LtgD reduce NOD2 activation in vitro, we also wanted to assess the role of 
NOD2 in pathogenesis.  In this study, we show that wild type mice that are infected with 
FA1090 ΔltgA/ΔltgD have a lower bacterial burden compared to mice infected with wild type 
FA1090 and that FA1090 ΔltgA/ΔltgD has a fitness defect in a competitive infection model.  
Deletion of ltgA and ltgD did not affect the persistence of infection in mice.  Finally, NOD2 does 
not appear to play a role in pathogenesis in the mouse model of infection, as no difference 
between bacterial burden or infection persistence was seen in Nod2
-/-
 mice infected with FA1090 
compared to wild type mice. 
3.2 Introduction 
Neisseria gonorrhoeae is a gram-negative pathogen that is the causative agent for the 
sexually transmitted infection gonorrhea.  During symptomatic infection in humans, N. 
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gonorrhoeae stimulates the production of inflammatory cytokines IL-17A and Il-23 that leads to 
the influx of polymorphonuclear leukocytes (PMNs) (Gagliardi et al., 2011).  This response is 
thought to be directed by IL-17 producing Th17 cells, which is observed in the murine model of 
infection (Feinen et al., 2010).  N. gonorrhoeae does not induce a protective adaptive immune 
response in the host.  Antibody titers of anti-gonococcal antibodies in patients with re-infection 
are no higher than in patients with first time infection, and re-infection can occur with the same 
N. gonorrhoeae serovar (Fox et al., 1999; Hedges et al., 1999; Hobbs et al., 1999).  In the mouse 
model of infection, N. gonorrhoeae has been shown to suppress a protective Th1/Th2 response 
through the induction of TGF-β (Liu et al., 2012).  The mechanism by which TGF-β induction 
occurs is unknown. 
During growth, N. gonorrhoeae release large quantities of cytotoxic anhydro 
peptidoglycan monomers.  PGN monomers released by N. gonorrhoeae contain one N-
acetylglucosamine-1,6-anhydro-N-acetylmuramic acid disaccharide unit linked to a peptide, 80% 
of which are the L-alanine-D-glutamic acid-meso-diaminopimelic acid tripeptide, with the 
remaining 20% composed mostly of terminal D-alanine containing tetrapeptide (Sinha and 
Rosenthal, 1980).  The tetrapeptide PGN monomer is structurally identical to the PGN 
monomers released by Bordetella pertussis, known as tracheal cytotoxin due to their ability to 
kill ciliated epithelial cells (Cookson et al., 1989; Goldman et al., 1982).  PGN monomers from 
N. gonorrhoeae have been shown to damage fallopian tube explants and induce inflammatory 
cytokine production (Chan et al., 2012; Melly et al., 1984).  It is hypothesized that this tissue 
damage may be important in the establishment of infection and transmission, though the effects 
of cytotoxic peptidoglycan monomers on cervical and urethral epithelium have not been studied.  
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The full extent to which N. gonorrhoeae PGN monomer release plays a role in pathogenesis and 
immune recognition of the bacteria is unknown. 
Inflammatory signaling in response to bacterial infections is mediated by the detection of 
pathogen-associated molecular patterns (PAMPs) through numerous extracellular and 
intracellular receptors.  The innate immune nucleotide-binding oligomerization domain-
containing protein 1 (NOD1) and 2 (NOD2) proteins are cytosolic sensors of bacterial 
peptidoglycan (PGN). Activation of NOD1 by PGN peptide chain component D-glutamyl-meso-
diaminopimelic acid (iE-DAP) in gram-negative bacteria and NOD2 by the muramyl dipeptide 
(MDP) moiety found in the PGN of most bacteria leads to the induction of NF-κB and 
inflammatory cytokine production (Chamaillard et al., 2003; Girardin et al., 2003a, 2003b; 
Inohara, 2003).  Both NOD1 and NOD2 have shown to play a role in directing the immune 
response to numerous pathogenic bacteria.  NOD1 has been shown to play a critical role in 
controlling the infection to Helicobacter pylori, as Nod1-/- mice were more susceptible to gastric 
infection.  This effect was dependent on PGN delivery to host cells through the action of the H. 
pylori type IV secretion system (Viala et al., 2004).  In vitro, NOD2 has been shown to play a 
role in controlling the growth of Mycobacterium tuberculosis in human monocyte-derived 
macrophages and primary mononuclear cells (Brooks et al., 2011; Ferwerda et al., 2005).  
Survival of Nod2-/- mice challenged with intraperitoneal Staphylococcus aureus was 
significantly reduced compared to wild type mice (Deshmukh et al., 2009).  In mouse 
neutrophils, NOD2, but not NOD1, directed the production of innate immune cytokines in 
response to several gram negative bacteria (Jeong et al., 2014).  NOD1 and NOD2 signaling in 
response to N. gonorrhoeae has recently been a topic of investigation.  Culture supernatants from 
N. gonorrhoeae robustly activate NOD1 and whereas activation of NOD2 is significantly less 
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(Mavrogiorgos et al., 2013).  This is likely due to the presence of 1,6-anhydro PGN monomers 
that are released into the supernatant of growing N. gonorrhoeae, which contain the iE-DAP 
moiety capable of activating NOD1 but are poorly activating of NOD2 due to the presence of the 
1,6-anhydro bond on the muramic acid sugar (Chapter 2, Section 2.4).  These PGN monomers 
are produced through the action of two lytic transglycosylases, LtgA and LtgD.  N. gonorrhoeae 
with the ltgA and ltgD genes deleted release multimeric PGN fragments rather than monomers 
(Cloud-Hansen et al., 2008). 
In this study we sought to determine the role of both NOD2 and the ltgA and ltgD genes 
in N. gonorrhoeae pathogenesis using the murine model of infection.  We found that N. 
gonorrhoeae lacking PGN processing by LtgA and LtgD had diminished bacterial burdens over 
the course of infection. A N. gonorrhoeae mutant with the ltgA and ltgD genes deleted, FA1090 
ΔltgA/ΔltgD, was impaired in competitive infections.  This indicates that the multimeric PGN 
released by these bacteria, which is capable of activating NOD2 more efficiently than PGN 
released from wild type N. gonorrhoeae, did not impact survival of the isogenic parent FA1090. 
In concordance with this, mice lacking NOD2 were not impaired in their ability to clear N. 
gonorrhoeae, suggesting that NOD2 signaling is not important in acute N. gonorrhoeae 
infection, at least in the mouse vaginal infection model.    
3.3 Materials and Methods 
3.3.1 Bacterial strains 
 For the competitive co-infections, FA1090 and FA1090 ΔltgA/ΔltgD were transformed 
with pCTS32 (Steichen et al., 2008) by spot transformation on GC agar as described previously 
to generate spectinomycin-resistant variants of each strain (Johnston and Cannon, 1999).  These 
strains were designated FA1090-spectinomycin and FA1090 ΔltgA/ΔltgD-spectinomycin. 
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N. gonorrhoeae strain FA1090 ΔltgA/ΔltgD (JD) was generated as described previously 
(Cloud and Dillard, 2002; Cloud-Hansen et al., 2008). Whole genome sequencing of FA1090 
ΔltgA/ΔltgD (JD) confirmed that the entire coding region of ltgD was deleted while the ltgA gene 
was disrupted by deletion of the last 1420 bp of the 1850 bp ltgA coding region and insertion of 
the ermC gene conferring erythromycin resistance.  A second construction of the ΔltgA/ΔltgD 
mutant, FA1090 ΔltgA/ΔltgD (KK) is described in Appendix 1. 
3.3.2  Experimental murine infection with N. gonorrhoeae 
Female BALB/c (4 to 6 weeks old) were purchased from The Jackson Laboratories, ME. 
BALB/c Nod2
-/-
 mice were a gift from Holly Rosenzweig (Rosenzweig et al., 2011) and age-
matched female BALB/c Nod2
-/-
 mice were obtained through in-house breeding.  Mice in the 
diestrus stage of the estrus cycle were started on a regimen of subcutaneous water-soluble 17β-
estradiol (0.5mg) two days prior to infection, the day of infection, and two days following 
infection to promote susceptibility to N. gonorrhoeae (Song et al., 2008).  Mice additionally 
received oral trimethoprim sulfate (0.04mg/mL), streptomycin sulfate (5mg/mL), and 
vancomycin (250μg/mL) in addition to intraperitoneal streptomycin sulfate and vancomycin 
twice daily (3.6mg and 0.6mg, respectively).  On the day of infection, mice were infected with 
Opa-matched 1x10
6
 CFU FA1090 or FA1090 ΔltgA/ΔltgD.  Vaginal mucus was collected daily 
with sterile swabs to assess commensal colonization and colonization with N. gonorrhoeae.  The 
bacterial load for each mouse was calculated by performing serial 10-fold dilutions of the vaginal 
samples in a 96-well plate and replica plating in at least triplicate onto GC-VCNTS agar. 
3.3.4 Competitive co-infection in mice 
Mice in the diestrus stage of the estrus cycle were selected for the study and made 
susceptible to N. gonorrhoeae with the administration of water-soluble 17β-estradiol and an oral 
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and intraperitoneal regimen of antibiotics as described above.  BALB/c mice were inoculated 
vaginally with equal CFU/mL FA1090-spectinomycin and FA1090 ΔltgA/ΔltgD or FA1090 and 
FA1090 ΔltgA/ΔltgD-spectinomycin for a total of 2x106 CFU per mouse.  Bacterial burden in 
each mouse was assessed using vaginal swabs as described above, and N. gonorrhoeae were 
replica plated on GC-VNTCS-spectinomycin and GC-VNTS agar.  Total burden was calculated 
from colonies counted on GC-VNTS agar.  The amount of bacteria without spectinomycin 
resistance was determined by subtracting the amount of N. gonorrhoeae recovered from the GC-
VNTCS-spectinomycin agar from total bacteria burden as calculated from GC-VNTS agar.  The 
presence of a spectinomycin resistance marker did not alter the ability of either FA1090 or 
FA1090 ΔltgA/ΔltgD to colonize mice relative to the isogenic N. gonorrhoeae strains without 
spectinomycin resistance. 
3.3.3 Characterization of inflammation 
The percentage of neutrophil influx was assessed by microscopic examination of stained 
vaginal smears.  Images were taken of at least three fields and the number of cornified epithelial 
cells, nucleated epithelial cells, and neutrophils were counted on each.  Data are expressed as a 
percentage of neutrophils relative to total cells in the field. 
3.3.4 Cytokine analysis of mouse derived dendritic cells 
Bone marrow was harvested from the femurs of euthanized mice and the cells were grown 
for 7 days in RPMI 1640 containing 10% inactivated FBS, penicillin/streptomycin, GM-CSF, 
and IL-4. The phenotype of BMDCs grown under these conditions has been verified via flow 
cytometry using cell markers CD11c and MHC II, and costimulation markers CD80, CD86, and 
CD40.  Cells were exposed to either live N. gonorrhoeae or N. gonorrhoeae culture supernatants 
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generated as described previously (Chapter 2, Section 2.3.3.) for 16 hours.  Supernatants were 
collected and cytokines were measured by ELISA (BD Scientific). 
3.4 Results 
3.4.1 Mice infected with ∆ltgA/∆ltgD N. gonorrhoeae have a lower bacterial burden 
compared to infection with wild type 
To assess the role of ltgA and ltgD in infection pathogenesis, female BALB/c mice were 
infected with either FA1090 ΔltgA/ΔltgD or wild type FA1090.  Vaginal samples were collected 
in PBS daily for ten days to monitor bacterial burden.  Samples were diluted serially10-fold and 
replica plated onto GC-VNTCS agar. Colonies at each dilution were counted to establish 
CFU/mL for each mouse on each day.  Bacteria recovered (CFU/mL) from infected mice on each 
day for mice infected with FA1090 or FA1090 ΔltgA/ΔltgD is shown in Figure 3.1A.  Area 
under the curve (AUC) for each infected mouse was calculated, and showed that the overall 
bacterial burden in mice infected with FA1090 ΔltgA/ΔltgD was significantly lower than mice 
infected with FA1090 N. gonorrhoeae (Figure 3.1B).  
3.4.2 Deletion of ltgA and ltgD does not impact infection persistence in vivo 
 The persistence of N. gonorrhoeae FA1090 or FA1090 ΔltgA/ΔltgD in BALB/c mice was 
monitored over the course of ten days.  Mice that were not positive for N. gonorrhoeae culture 
on day 10 were considered to have cleared the infection on the day after the last day detectable 
levels of N. gonorrhoeae were recovered from vaginal swabs.  Mice in which N. gonorrhoeae 
was never recovered during the 10 days of monitoring were considered to not have been infected.  
Deletion of ltgA and ltgD may play a role in early infection, as there was a statistically 
significant difference in persistence of infection up to day 4 (Figure 3.2).  However, this may 
simply reflect the low bacterial burden characteristic of FA1090 ΔltgA/ΔltgD that was frequently 
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below the lower limit of detection of the assay, as demonstrated in some mice by several days of 
no N. gonorrhoeae recovery followed by at least one day of positive culture.  Over the total 
course of 10 days there was not a statistically significant difference in the persistence of infection 
between FA1090 and FA1090 ΔltgA/ΔltgD. 
3.4.3 Inflammatory responses to FA1090 ΔltgA/ΔltgD in mice 
We measured inflammatory cytokine response in mouse bone marrow derived dendritic 
cells (BMDCs) to determine if mouse cells would respond similarly to N. gonorrhoeae FA1090 
and FA1090 ΔltgA/ΔltgD at human THP1 and primary blood dendritic cells discussed in Chapter 
2 (Figure 2.1A-C).  Mouse BMDCs were exposed to N. gonorrhoeae culture supernatants and 
IL-1β and TNF-α secretion was measured in the supernatants.  As with the human cells lines 
tested previously, mouse BMDCs produced more inflammatory cytokines IL-1β and TNF-α in 
response to culture supernatants from FA1090 ΔltgA/ΔltgD compared to wild type FA190 
(Figure 3.3A). 
We assayed mice infected with N. gonorrhoeae for inflammation by counting the number 
neutrophils relative to other cells present on slides of vaginal swabs.  In experimental mice that 
N. gonorrhoeae was never recovered from, no neutrophils were observed.  In mice that were 
positive for N. gonorrhoeae infection, 3/7 mice infected with FA1090 were positive for 
neutrophil influx on at least one day and in mice infected with FA1090 ΔltgA/ΔltgD (KK) 
(construction described in Appendix 1) 1/6 mice were positive for neutrophil influx.  Neutrophil 
influx on average was higher in FA1090-positive mice, with a mean of 3%, 5%, and 2% on days 
5, 6, and 7 respectively, though there was considerable variation between mice.  In FA1090 
ΔltgA/ΔltgD-positive mice, the mean neutrophil influx was 0%, 0%, and 0.2% for days 5, 6, 7 
respectively (Figure 3.3B).  Thus while FA1090 ΔltgA/ΔltgD does induce influx of PMNs, 
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inflammation is less than FA1090, which does not recapitulate the increased inflammatory 
cytokine release by isolated dendritic cells or monocyte cell lines that we have observed in cell 
culture-based experiments. However, bacterial loads in mice infected with FA1090 ΔltgA/ΔltgD 
were lower than mice infected with FA1090, and sample numbers were low for each group.    
3.4.4 The ∆ltgA/∆ltgD N. gonorrhoeae mutant has a fitness defect in competitive infection in 
vivo 
To evaluate whether or not the release of PGN multimers, rather than monomers, could 
act on the host in trans to reduce gonococcal colonization by both wild type and mutant FA1090, 
we performed a competitive co-infection with FA1090 in wild type BALB/c mice.  If FA1090 
ΔltgA/ΔltgD is defective in single infection when compared to wild type FA1090, but not 
defective when compared to wild type in competitive infection, it could suggest that either the 
multimeric PGN acts in trans to reduce survival of FA1090 or that secretion of monomer by wild 
type N. gonorrhoeae is capable of acting in trans to enhance mutant. In contrast, the 
predominance of FA1090 over FA1090 ΔltgA/ΔltgD would reflect an intrinsic survival defect in 
the mutant.  For each mouse on each day that were positive for N. gonorrhoeae, the competitive 
index (CI) was calculated.  The CI is defined as follows: 
    
 
                  
                       
 
                  
                      
 
 
The log(CI) reflects the relative fitness of FA1090 and FA1090 ΔltgA/ΔltgD, where log(CI) = 0 
reflects an equal fitness and log(CI) > 0 or log(CI) < 0 reflects a fitness defect in FA1090 or in 
FA1090 ΔltgA/ΔltgD respectively.  Over the course of a 10 day infection, the log(CI) was 
significantly below 0 on each day, except on days where the dynamic range of the assay was 
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reduced as a result of low bacterial recovery (Figure 3.4A and 3.4B).  Individual mice are noted 
by different symbols and/or symbol color.  Mice not appearing as a data point on a single day 
were the result of no recovery of N. gonorrhoeae on that day.  The data show that FA1090 
ΔltgA/ΔltgD has a fitness defect in vivo that was not recovered by the presence of 1,6-anhydro 
PGN monomers produced during co-infection by FA1090.  Similarly, the survival of FA1090 in 
vivo was not affected by the presence of multimeric PGN. 
3.4.5 NOD2 does not play a role in N. gonorrhoeae pathogenesis in the murine model of 
infection 
 Given that N. gonorrhoeae PGN release is known to cause inflammatory cytokine 
production by host cells in cell culture, we additionally sought to study the role of NOD2 in N. 
gonorrhoeae pathogenesis.  To test the role of NOD2 in the pathogenesis of N. gonorrhoeae 
infection, we infected Nod2
-/-
 and wild type mice with FA1090.  N. gonorrhoeae was collected 
from mice and quantified by replica plating on GC-VNTCS agar as previously described.    
Nod2
-/-
 mice had the same bacterial burden and persistence of infection as wild type time mice 
over the course of a 10 day infection (Figure 3.5A-C). 
3.5 Discussion 
 The role of PGN monomer production and release by N. gonorrhoeae in pathogenesis is 
not fully elucidated.  PGN monomers from both N. gonorrhoeae and Bordetella pertussis are 
well-documented to cause death of fallopian tube epithelial cells and ciliated cells of the tracheal 
epithelium, respectively (Goldman et al., 1982; Melly et al., 1984). Here we show that the lytic 
transglycosylase proteins LtgA and LtgD responsible for producing these anhydro PGN 
monomers are important in N. gonorrhoeae colonization of the female mouse genital tract.  N. 
gonorrhoeae that have the ltgA and ltgD genes deleted have a fitness defect in vivo and are poor 
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colonizers of the infection site. Whether or not this is a direct consequence of PGN multimer 
release, failure of monomer release, or the result of yet-to-be characterized effects of ltg deletion, 
such as effects on cell wall integrity or PGN recycling in vivo, is unknown.   
We also studied the role of NOD2 in N. gonorrhoeae pathogenesis using Nod2
-/-
 mice.  
Somewhat surprisingly, we found that Nod2
-/-
 mice had a similar bacterial burden and 
persistence of infection as wild type mice.  One possible explanation for this is the possibility 
that N. gonorrhoeae, an obligate human pathogen, has been fine-tuned to the immune signaling 
of its human host.  Mice are not naturally susceptible to infection with N. gonorrhoeae and only 
become susceptible under administration of 17β-estradiol as well as antibiotics to reduce 
commensal colonization.  Differences in ligand specificity between mouse NOD1 and human 
NOD1 have been demonstrated.  Mouse NOD1, for example, is able to recognize 1,6-anhydro 
tetrapeptide PGN monomer, while human NOD1 cannot (Magalhaes et al., 2005).  During 
growth, about 20% of the 1,6-anhydro PGN monomers released are the tetrapeptide monomer, 
while most of the remaining are 1,6-anhydro tripeptide PGN monomer (Sinha and Rosenthal, 
1980).  Ligand recognition differences between mouse NOD2 and human NOD2, particularly in 
the context of recognizing 1,6-anhydro PGN fragments, has not been studied.  Such differences 
could manifest in an in vivo mouse model infection as compensatory or alternate critical immune 
signaling for control of infection that are not relevant in human infection.  Examples of this have 
been demonstrated in vitro, where NOD2 was shown to be important in controlling 
Mycobacterium tuberculosis infection in human, but not mouse, macrophages (Brooks et al., 
2011). Thus, the lack of a phenotype in Nod2
-/-
 mice in N. gonorrhoeae infection is not a 
definitive indication that NOD2 does not play a role in infection in humans. 
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An alternative explanation may be supported by our previous findings, reported in 
Chapter 2, which show that 1,6-anhydro PGN monomers released by N. gonorrhoeae are poorly 
activating of NOD2.    The role of NOD2 in detection of N. gonorrhoeae has only recently been 
reported on, and its function has not been tested in vivo through use of a mouse model.  Culture 
supernatants from growing N. gonorrhoeae are poor activators of NOD2 (Mavrogiorgos et al., 
2013).  Our data showing no role for NOD2 in either controlling bacterial burden or infection 
persistence in vivo may confirm in vitro findings that wild type N. gonorrhoeae is a poor 
activator of NOD2.  An interesting question then arises regarding the role of NOD2 in N. 
gonorrhoeae infection.  Given that NOD2 has been shown to play a role in many innate and 
adaptive immune responses—including autophagy, antimicrobial peptide production, and antigen 
presentation—avoiding NOD2 activation may be beneficial to survival in the host (Cooney et al., 
2009; Travassos et al., 2009; Voss et al., 2006).  Since we have observed in vitro that FA1090 
ΔltgA/ΔltgD causes increased production of inflammatory cytokines and is more activating of 
NOD2, infection of Nod2
-/-
 mice with FA1090 ΔltgA/ΔltgD might better demonstrate the 
interplay between N. gonorrhoeae and NOD2.  If NOD2 signaling is responsible for the poor 
fitness of FA1090 ΔltgA/ΔltgD in vivo, then Nod2-/- mice infected FA1090 ΔltgA/ΔltgD would 
have elevated bacterial burdens compared to wild type mice. 
FA1090 ΔltgA/ΔltgD does not appear to be more inflammatory in vivo, in contrast to in 
vitro data showing that mouse BMDCs produce more IL-1β and TNF-α in response to culture 
supernatants from FA1090 ΔltgA/ΔltgD when compared to cytokine production in response to 
wild type FA1090.  Our in vivo characterization is limited to neutrophil influx, however, and 
may not sufficiently quantify the full extent of local inflammation.  It may explain, however, 
why FA1090 ΔltgA/ΔltgD is able to survive in the mouse host for a similar length of times as 
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FA1090.  Ultimately, the bacterial burdens in mice infected with FA1090 ΔltgA/ΔltgD may be 
too low to trigger sufficient PMN migration, and this may explain the higher percentage of 
PMNs in FA1090 infected mice.  Additional experiments are needed in order to make a 
conclusion regarding the correlation between bacterial burden and PMN influx.  There are also 
other markers of inflammation that can be investigated.  While the ability to obtained 
quantifiable levels of local cytokines can be challenging, physical infection of excised mouse 
genital tract tissues during infection or quantification of mRNA expression for various host 
inflammatory responses may reveal a more complete understanding of inflammation induced by 
FA1090 ΔltgA/ΔltgD. 
However, the possibly exists that the mechanism that confers a defect in FA1090 
ΔltgA/ΔltgD colonization of the mouse genital tract may not be host mediated.  Another lytic 
transglycosylase, LtgC, is required for separation and bacteria with ltgC deleted have an 
observed growth defect in vitro (Cloud and Dillard, 2004). While deletion of ltgA and ltgD has 
not been reported to confer a growth defect in vitro (Cloud-Hansen et al., 2008, and Chapter 2 
Figure 2.1), a growth defect in FA1090 ΔltgA/ΔltgD may not be observable in liquid culture, 
which is challenging with N. gonorrhoeae as the bacteria undergo significant lysis after less than 
24 hours.  A minor growth defect may become more significant in a long-term in vivo growth 
scenario such as the murine model of infection, which may result in the lower bacterial burden 
and fitness defect.  In support of data showing that ltgA and ltgD deletion does not have a growth 
defect phenotype, in Vibrio fischeri deletion of ltgA and ltgD, which have a similar function in 
PGN monomer production, also does not result in a growth defect or changes in cell morphology 
(Adin et al., 2009).  That considered, there may be other consequences to deletion of ltgA and 
ltgD, such as integrity of the cell wall, which may reduce resistance to host antimicrobial factors. 
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Evaluation of survival of FA1090 ΔltgA/ΔltD in the presence of serum, antimicrobial peptides, 
ROS, or other stressors is needed to determine if loss of resistance to host antimicrobial factors is 
an explanation for the colonization defects observed in vivo. 
Our data demonstrate for the first time a role for LtgA and LtgD in pathogenesis in vivo 
in the pathogenic bacteria N. gonorrhoeae, and these proteins may be an important target of 
study in other bacteria where PGN release in an important factor in host-pathogen interaction. 
Additional research is needed to understand the mechanisms by which the deletion of ltgA and 
ltgD confer a fitness defect in vivo.  These include investigations into the known PGN 
recognition receptors, including NOD2, through the use of Nod2
-/-
 mice or siRNA knockdown of 
NOD2 in human cell lines and evaluation of resistance to host antimicrobial factors.  Given the 
variable expression of NOD2 in different cell types, the site of infection may be important.  This 
presents another possible limitation of using the mouse model for these studies, as the infection 
site in mice is the vagina, whereas the infection site in humans is typically the cervix or the 
urethra.  It is possible that NOD2 signaling not important for acute clearance of bacteria but 
plays a role in inducing a protective adaptive immune response.  In that case, there might be 
selective pressure to avoid NOD2 signaling even if there is no benefit in acute infection. As an 
alternate to studies involving NOD2, our previous in vitro findings show that FA1090 
ΔltgA/ΔltD also increases TLR2 activation, which may mediate the reduced survival of the 





Figure 3.1. Mice infected with FA1090 ΔltgA/ΔltgD have a lower bacterial burden 
compared to mice infected with wild type N. gonorrhoeae. 
BALB/c mice were infected with either FA1090 or FA1090 ΔltgA/ΔltgD (JD).  Bacterial burden 
was monitored daily with vaginal swabs.  A) Amount of N. gonorrhoeae recovered from mice on 
each day.  Graph shows data for mice known to be colonized with N. gonorrhoeae. A value of ½ 
lower limit of detection (LLD) was used when N. gonorrhoeae was not recovered from a mouse 
on one day but was recovered on a subsequent day.  B) Area under the curve (AUC) of bacterial 
burden for each mouse over the course of the experiment.  Data shown are a combination of two 
separate experiments. Data were analyzed using GraphPad Prism 6. AUC data was analyzed by 






Figure 3.2. Deletion of ltgA and ltgD does not affect infection persistence of N. gonorrhoeae 
in the mouse model. 
Mice were infected with either FA1090 or FA1090 ΔltgA/ΔltgD and the persistence of infection 
was monitored over the course of ten days using vaginal swabs.  Data shown were the 
combination of two independent experiments. All data was analyzed using GraphPad Prism 6. 





Figure 3.3. Increased inflammatory responses to FA1090 ΔltgA/ΔltgD in vitro do not 
replicate in vivo. 
Primary mouse bone marrow derived dendritic cells (BMDCs) were exposed to culture 
supernatants from FA1090 and FA1090 ΔltgA/ΔltgD and assayed for production of A) IL-1β and 
TNF-α.  Mice infected with FA1090 or FA1090 ΔltgA/ΔltgD were assayed for vaginal neutrophil 
influx (B).  Data from days five, six, and seven of mice for which N. gonorrhoeae was recovered 
(+Ng) or not recovered (-Ng) during the course of the experiment are shown.  Data are shown as 
the mean percent of neutrophils in all mice.  The percent of neutrophils for an individual mouse 
is the mean number of neutrophils relative to other cells types calculated from at least three fields 
with a total of at least 100 cells.  Cytokine data are representative of at least three independent 
experiments with at least three independent preparations of culture supernatant.  In vivo data are 
the combination of two independent experiments (see Appendix 3). Data were analyzed by 
GraphPad Prism 6. Error bars represent +/- S.E.M. Significance was determined using Student’s 




Figure 3.4. Deletion of ltgA and ltgD in N. gonorrhoeae confers a fitness defect in vivo. 
A competitive co-infection with FA1090 and FA1090 ΔltgA/ΔltgD was used to evaluate the 
relative fitness of FA1090 ΔltgA/ΔltgD.  Bacterial loads of each were calculated from vaginal 
swabs taken daily.  Competitive index (CI) is defined as FA1090 
ΔltgA/ΔltgDrecovered/FA1090recovered and is normalized for differences in the inoculum. A) Log(CI) 
for each mouse on each day.  Data are only shown for mice in which N. gonorrhoeae was 
recovered on that day.  Each mouse in the study is represented by different symbols and/or 
symbol colors. B) Data showing average total recovered N. gonorrhoeae (FA1090 + FA1090 
ΔltgA/ΔltgD).  Mice in which no N. gonorrhoeae was recovered are excluded.  Data shown is the 
combination of two independent experiments.  Data were analyzed using GraphPad Prism 6.  CI 
data was assessed for being significantly different from 0.  Data were confirmed to be normally 
distributed using a Shapiro-Wilk normality test and significance was determined on each day 






Figure 3.5. NOD2 does not play a role in controlling N. gonorrhoeae infection. 
BALB/c WT or Nod2-/- mice were infected with N. gonorrhoeae FA1090.  Daily vaginal swabs 
were used to monitor bacterial burden over the course of ten days.  Neither bacterial burden nor 
infection persistence was altered in Nod2
-/-
 mice.  A) Amount of N. gonorrhoeae recovered from 
mice on each day.  Graph shows data for mice known to be colonized with N. gonorrhoeae. A 
value of ½ lower limit of detection (LLD) was used when N. gonorrhoeae was not recovered 
from a mouse on one day but was recovered on a subsequent day.  B) Area under the curve 
(AUC) of bacterial burden for each mouse over the course of the experiment. C) Persistence of 
N. gonorrhoeae infection.  Data shown is the combination of two independent experiments. All 
data were analyzed using GraphPad Prism 6. AUC data were analyzed by Student’s t-test.  





Discussion and Future Directions 
4.1 Discussion
The precise role of peptidoglycan monomer release and NOD2 signaling in the 
pathogenesis of N. gonorrhoeae infection has not been well studied.  NOD2 is involved in the 
induction of many host responses that have been shown to be suppressed during N. gonorrhoeae 
infection or that N. gonorrhoeae is resistant to.  For example, NOD2 is known to mediate MHC 
class II antigen-specific CD4+ responses and facilitate polarization of Th2 cells in response to 
those antigens (Cooney et al., 2009; Magalhaes et al., 2008).  In the mouse model of N. 
gonorrhoeae, induction of Th2 responses enhance rate of bacterial clearance (Liu and Russell, 
2011; Liu et al., 2013). Th2 responses to infection are suppressed by N. gonorrhoeae-induced 
TGF-β secretion, which in the context of other inflammatory cytokines leads to the 
predominance of Th17 responses (Liu et al., 2012).  Activation of NOD2 by MDP has been 
shown to stimulate production of antimicrobial peptides like HNP1 and -defensin-2 (Voss et al., 
2006; Yamamoto-Furusho et al., 2010).  N. gonorrhoeae is able to survive intracellularly even in 
cells capable of producing antimicrobial peptides, and is resistant to various host antimicrobial 
agents, including bile salts, progesterone, and antimicrobial peptides (Criss et al., 2009; Hagman 
et al., 1995; Jerse et al., 2003; Shafer et al., 1998). Nevertheless, while our studies implicate 
reduced NOD2 signaling as a mechanism of action of the lytic transglycosylases LtgA and LtgD 
in vitro, N. gonorrhoeae infection in Nod2
-/- mice progressed similarly to infection in wild type 
mice.  It is possible that mouse recognition of PGN through NOD1, NOD2, or other signaling 
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pathways is sufficiently different than PGN signaling in humans to explain this discrepancy.  
There is evidence for ligand specificity differences between mouse and human NOD1, as mouse 
but not human NOD1 can recognize tetrapeptide 1,6-anhydro PGN monomer known at tracheal 
cytotoxin that is released from Bordetella pertussis (Magalhaes et al., 2005). NOD2 is  able to 
control Mycobacterium tuberculosis infection in vitro in human macrophages but not in mouse 
macrophages (Brooks et al., 2011).  Differences between mouse and human NOD2 with regards 
to 1,6-anhydro PGN recognition and activation have not been studied.  It seems unlikely that N. 
gonorrhoeae would release sufficient quantities of monomeric PGN as to cause epithelial cell 
damage while also minimizing NOD2 recognition of these fragments if NOD2 was not relevant 
to pathogenesis.  The 1,6-anhydro bond that interferes with human NOD2 signaling does not 
play a role in inducing ciliated cell death; only a portion of the peptide chain, lactyl-D-glutamic 
acid-meso-diaminopimelic acid, is required for the toxic function of PGN monomers (Luker et 
al., 1995).  In the context of our own in vitro data and data published by another group, N. 
gonorrhoeae culture supernatants are poorly activating of NOD2 (Mavrogiorgos et al., 2013).  
Our data showing that Nod2
-/-
 mice maintain similar bacterial burdens and persistence of 
infection as wild type mice may reflect that in vivo N. gonorrhoeae minimally activates NOD2 
during infection.  Culture supernatants from the lytic transglycosylase deletion mutant FA1090 
ΔltgA/ΔltgD is a superior activator of human NOD2 in vitro relative to wild type FA1090, likely 
due to the presence of large, multimeric PGN complexes (Chapter 2, Section 2.X).  Infection of 
Nod2
-/-
 mice with the mutant strain may reveal a function of NOD2 in infection and the survival 
benefit for evasion of NOD2 activation.  Such studies, along with those described in Chapter 4, 




 Despite a the lack of involvement of mouse NOD2 in controlling infection with N. 
gonorrhoeae, the LtgA and LtgD proteins responsible for the production of released 1,6-anhydro 
PGN monomers do demonstrate a role in pathogenesis in the mouse model of infection and 
inflammatory response in vitro.  In vitro LtgA and LtgD reduces inflammatory signaling, as 
exposure to live FA1090 ΔltgA/ΔltgD or culture supernatants induces the production of 
significantly more IL-1β and TNF-α compared to wild type FA1090 in a variety of cell types, 
including THP1 cells, human primary blood dendritic cells, and mouse bone marrow derived 
dendritic cells.  This is likely partially due to an increase in NOD2 signaling by releasing PGN 
multimers rather than PGN monomers with a 1,6-anhydro bond addition on the muramic acid 
sugar.  We show that 1,6-anhydro PGN monomers are poor activators of NOD2.  In contrast 
reducing forms of PGN, produced through the action of host lysozyme on multimeric PGN, are 
in contrast highly activating of NOD2.  The lack of a significant increase in NOD1, TLR4, and 
TLR9 activation in response to culture supernatants from FA1090 ΔltgA/ΔltgD suggests the 
increased NOD2 response is not simply the result of higher levels of bacterial compounds—
DNA, LPS, or NOD1-activating PGN—but is rather specific to an increase quantity of NOD2-
activating PGN, presumably multimeric PGN that is subsequently being digested by host 
lysozyme.  The finding that the addition of the 1,6-anhydro bond on the muramic acid sugar of 
PGN monomers blocks NOD2 activation has not been previously reported and is an important 
addition to the literature in understanding innate immune recognition of bacteria.   
Interestingly, we did observe an increase in TLR2 activation in response to culture 
supernatants from FA1090 ΔltgA/ΔltgD.  The role of TLR2 in PGN signaling has been disputed 
in the literature.  PGN was originally identified as a TLR2 ligand, but subsequent studies that 
used rigorous purification methods on bacterial-derived PGN showed no activation of TLR2, 
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suggesting that contaminates such as teichoic acid or PGN-associated lipoproteins were 
activating TLR2 (Schwandner et al., 1999; Takeuchi et al., 1999b; Travassos et al., 2004; 
Yoshimura et al., 1999).  However, a response paper to that study used similar stringent 
purification methods on Staphylococcus aureus-derived PGN showed that multimeric S. aureus 
PGN was an activator of TLR2 (Dziarski and Gupta, 2005).  Additional studies have since 
demonstrated a role of TLR2 in recognition of S. aureus PGN through co-localization with 
NOD2, and that multimeric PGN from Δlgt S. aureus mutants, which lack lapidated 
prelipoproteins, is not recognized by TLR2 alone (Müller-Anstett et al., 2010; Volz et al., 2010). 
Our results do not show a significant difference in the activation of TLR2 between multimeric 
and monomeric PGN, and both PGN species only weakly activate TLR2. The increased capacity 
to induce TLR2 activation by culture supernatants from FA1090 ΔltgA/ΔltgD is likely due to 
increased quantities of known TLR2 stimulating proteins from N. gonorrhoeae, PorB and Lip 
(Fisette et al., 2003; Massari et al., 2002).  Release of these TLR2-activating polypeptides may 
accompany the release of larger PGN multimers that are not processed into 1,6-anhydro-
MurNAc-containing PGN monomers in FA1090 ΔltgA/ΔltgD. 
LtgA and LtgD appear to have a distinct role in pathogenesis based on in vivo data from 
the mouse model of infection.  There is a significantly lower bacterial burden in mice infected 
with FA1090 ΔltgA/ΔltgD compared to mice infected with FA1090.  Further, FA1090 
ΔltgA/ΔltgD has a clear fitness defect, as demonstrated by competitive infection with mice. 
Despite this, there was no observable difference in the persistence of infection in the mutant 
compared to the wild type, though there may be a difference in the early establishment of 
infection by FA1090 ΔltgA/ΔltgD.  This could be partially explained by the low number of local 
neutrophils observed in response to FA1090 ΔltgA/ΔltgD compared to FA1090.  In vitro, 
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FA1090 ΔltgA/ΔltgD induces the production of more IL-1β and TNF-α compared to FA1090.  
The discrepancy between the in vitro and in vivo data may be explained by the low bacterial 
burden characteristically observed in mice infected with FA1090 ΔltgA/ΔltgD.  Bacterial 
numbers of FA1090 ΔltgA/ΔltgD may not be high enough to induce significant inflammation, 
and are therefore able to persist for a similar amount of time as FA1090. 
Lytic transglycosylases have been implicated in other bacteria as being important to 
virulence, but in those contexts the lytic transglycosylases play a role in cell separation or cell 
wall dynamics that are thought to be important in interaction with host cells (Bartoleschi et al., 
2002; Stapleton et al., 2007).  An example more relevant to the action of lytic transglycosylases 
in PGN release involves Vibrio fischeri, an organism whose PGN monomer release is important 
in its symbiotic relationship with the Hawaiian bobtail squid (Koropatnick, 2004).  A 
ΔltgA/ΔltgD mutant of V. fischeri, which, similar to ΔltgA/ΔltgD N. gonorrhoeae produces 
significantly less PGN monomer, did not have a colonization or fitness defect when tested in vivo 
in squid (Adin et al., 2009).  Our data are the first to report on the possible colonization defects 
in pathogenic bacteria that occur as a result of deletion of the lytic transglycosylases responsible 
for PGN monomer production.   
Our current data do not provide a mechanistic explanation for the reduced fitness of 
FA1090 ΔltgA/ΔltgD in the mouse model.  Though mouse NOD2 does not appear important in 
infection with wild type N. gonorrhoeae, this does not exclude the possibility of a role for NOD2 
in response to FA1090 ΔltgA/ΔltgD.  Gonococci may be more susceptible to killing by host 
phagosomes due to the increased production of NOD2-activating PGN.  Subsequent pathways 
downstream of NOD2, such as autophagy or the induction of host antimicrobial peptides may be 
detrimental to phagocytosed organisms.  Comparing the bacterial burden of FA1090 
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ΔltgA/ΔltgD and FA1090 wild type in a Nod2-/- mouse could provide an answer to this question.  
Alternatively, despite lack of in vitro evidence that deletion of ltgA and ltgD cause growth 
defects, these mutants may a growth defect in vivo.  These lytic transglycosylase mutants may 
also have increased susceptibility to host antimicrobial factors. 
4.2 Future Directions 
 The studies presented here investigate the role the monomers play in pathogenesis, 
inflammation, and receptor activation by disrupting the production of 1,6-anhydro peptidoglycan 
monomers in N. gonorrhoeae through the deletion of the genes encoding two lytic 
transglycosylases, ltgA and ltgD.  This approach has led to the discovery that LtgA and LtgD 
have a distinct role in suppressing inflammation, through both NOD2 as a result of PGN 
breakdown and through TLR2 by an unknown mechanism.  Additionally, N. gonorrhoeae 
lacking LtgA and LtgD are poor colonizers of the female mouse genital tract and have a clear 
fitness defect in vivo.  However, there are some critical limitations in using this approach to 
understanding the role of PGN monomers in N. gonorrhoeae infection.  N. gonorrhoeae lacking 
LtgA and LtgD are still releasing large quantities of peptidoglycan.  Production and release of 
these multimeric fragments still expose the host to a NOD1-activating ligand, as we have shown 
here (Chapter 2, Section 2.X).  Additionally, like monomeric PGN, the multimeric fragments 
contain the peptide chain moiety responsible for epithelial cell damage that occurs during 
infection (Luker et al., 1995; Melly et al., 1984).  Thus, other approaches, such as altering the 
amount of PGN released by N. gonorrhoeae, provide an important extension to the studies on N. 
gonorrhoeae PGN discussed here. 
 Deletion of the ampD or ampG in N. gonorrhoeae provides such an opportunity.  
Deletion of ampD, whose protein product AmpD is a cytoplasmic N-acetylmuramyl-l-alanine 
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amidase, results in N. gonorrhoeae whose levels of PGN release are significantly reduced 
(Garcia and Dillard, 2008).  A reduction in PGN release can also be achieved by replacing the           
gonococcal ampG, a permease, with meningococcal ampG, resulting in a reduction of PGN 
release from 15% to 4%, an amount similar to that observed in other gram-negative bacteria such 
as Escherichia coli (Woodhams et al., 2013).  This occurs as a result of meningococcal ampG 
being more efficient at recycling PGN than gonococcal ampG.  A similar strategy was used in 
the construction of an attenuated Bordatella pertussis strain for vaccine use, where B. pertussis 
ampG was replaced with E. coli ampG to reduce the amount of toxic PGN monomers released 
(Mielcarek et al., 2006). An increase in PGN monomer release can also be achieved: deletion of 
ampG in N. gonorrhoeae causes a substantial (7-fold) increase in the amount of PGN released 
(Garcia and Dillard, 2008). Both the ampG and ampD deletion mutants are reported to have 
similar in vitro growth characteristics to the isogenic wild type strain, and thus in that respect are 
suitable for in vitro and in vivo studies using live N. gonorrhoeae.  Identification of a phenotype 
for ampG or ampD mutant N. gonorrhoeae in vivo using the mouse model of infection in 
comparative and competitive infections with the wild type strain could provide further insights 
into the role of PGN in vivo.  Use of these strains could also open up avenues of in vitro studies 
on PGN release including recognition and killing of N. gonorrhoeae by neutrophils or infiltrating 
APCs.  Because ΔltgA/ΔltgD N. gonorrhoeae appear to produce equal amounts of NOD1-
stimulating ligand during growth as wild type (Chapter 2, Section 2.X), the use of ΔampD N. 
gonorrhoeae would reduce the total amount of released PGN and mechanistic roles for both 
NOD1 and NOD2 in triggering an immune response could be better explored.  The same follows 
for use of ΔampG, which would increase the amount of NOD1 and NOD2-activating PGN, the 
latter of which is notably present in only minimal quantities, due to the majority of released PGN 
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being the 1,6-anhydro monomer, which does not activate NOD2.  An ampG mutant of Shigella 
flexneri that released more PGN than wild type was found to increase NOD1, but not NOD2 
activation (Nigro et al., 2008).  
 There are reported differences between the ligand specificities and role in controlling the 
immune response to bacterial infection between human and mouse NOD1 and NOD2 that may 
represent a clear limitation of studying N. gonorrhoeae PGN in a mouse infection model and 
using mouse-derived cells.  Mouse NOD1 can recognize tetrapeptide PGN monomer, while 
human NOD1 cannot (Magalhaes et al., 2005).  Differences in NOD2 signaling between mouse 
and human concerning the anhydro PGN fragments discussed in Chapter 2 have not been 
reported and such an experiment may provide insight into the relevancy of the mouse model of 
N. gonorrhoeae infection.  Human NOD2 has been shown to play a role in the control of 
Mycobacterium tuberculosis in macrophages in vitro while mouse NOD2 does not (Brooks et al., 
2011).  Thus, even if mouse NOD2 has similar limitation in detecting PGN fragments that 
contain a 1,6-anhydro bond, there may be critical differences in downstream signaling. 
 Given these potential problems with the mouse model of infection discussed above, use 
of the human model of infection in men to study the role of monomeric PGN release in N. 
gonorrhoeae infection may provide the only relevant data for this scientific question.  The use of 
this model presents its own scientific challenges—low numbers of volunteers, studies are limited 
to infection of the male urethra, for example—but a competitive co-infection with FA1090 and 
FA1090 ΔltgA/ΔltgD (or FA1090 ΔampD or ΔampD if preliminary studies prove sufficiently 
interesting) would reveal the role of LtgA and LtgD in the fitness of this bacteria in humans.  In 
vitro studies making use of siRNA to knockdown NOD2 or NOD1 in human primary or 
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immortalized cells could provide some mechanistic explanations of an observed in vivo 
phenotype. 
 There is still a significant amount of work to be done in understanding the role of N. 
gonorrhoeae PGN and PGN receptors—including NOD1 and NOD2—in infection.  
Undoubtedly additional proteins that function to regulate the production and release of 
monomeric PGN will be discovered in the future.  Currently the mechanism by which PGN 
monomers are transported, actively or passively, across the cell membrane is unknown.  Further 
characterization, both in vivo and mechanistically, of N. gonorrhoeae mutants that disrupt wild 
type monomeric PGN release are needed to add to the understanding of how N. gonorrhoeae 





APPENDIX 1: CONSTRUCTION OF FA1090 ΔLTGA/ΔLTGD (KK) 
Alternate construction of FA1090 ΔltgA/ΔltgD 
N. gonorrhoeae strain FA1090 ΔltgD was generated as described previously (Cloud and Dillard, 
2002; Cloud-Hansen et al., 2008) and deletion was confirmed by PCR.  Construction of FA1090 
ΔltgA/ΔltgD (KK) was done in FA1090 ΔltgD using the ermC/rpsl ltgA insert plasmid described 
previously by spot transformation on GC agar (Johnston and Cannon, 1999).  Erythromycin-
resistant colonies were chosen, and insertion of the plasmid was confirmed by PCR.  However, a 
PCR product of the repair plasmid insertion was used to retransform the mutant, rather than 
using the repair plasmid as described.  Transformants were selected on streptomycin and were 
confirmed to have erythromycin susceptibility.  Clean deletion of ltgA was confirmed by PCR, 





APPENDIX 2: FA1090 ΔLTGA/ΔLTGD (KK) IN VITRO DATA 
FA1090 ΔltgA/ΔltgD (KK) has a similar in vitro phenotype as FA1090 ΔltgA/ΔltgD (JD). 
As seen with FA1090 ΔltgA/ΔltgD (JD), FA1090 ΔltgA/ΔltgD (KK) induces the production of 
more inflammatory cytokines IL-1β and TNF-α in comparison to wild type FA1090 in human 
derived cell lines.  This was reproducible with both PMA-stimulated THP1 cells exposed to live 
N. gonorrhoeae (MOI 0.1) and THP1 cells exposed to N. gonorrhoeae culture supernatants, 
which were generated as described in Chapter 2.  Similar phenotypes are also observed in 
transfected immune receptor-expressing cells.  FA1090 ΔltgA/ΔltgD (KK) was more activating 




FA1090 ΔltgA/ΔltgD (KK) produces similar inflammatory and receptor activation 
responses as FA1090 ΔltgA/ΔltgD (JD) 
A) PMA-treated THP1 cells were exposed to live N. gonorrhoeae (multiplicity of infection: 0.1) 
and production of IL-1β and TNF-α in the cell culture supernatant was measured by ELISA.  
Data are representative of two independent experiments. B) THP1 cells were exposed to N. 
gonorrhoeae culture supernatants and production of IL-1β and TNF-α was measured by ELISA.  
HEK293 cells transfected with a secreted alkaline phosphatase reporter and C) NOD1, D) 
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NOD2, or E) TLR2 were exposed to N. gonorrhoeae culture supernatant.  Data are expressed as 
fold activation over basal levels of activation in response to graver wade media controls.  For 
experiments using N. gonorrhoeae culture supernatants, data is representative of at least two 
independent experiments with at least two preparations of culture supernatants.  Data were 




APPENDIX 3: FA1090 ΔLTGA/ΔLTGD (KK) IN VIVO DATA 
 
FA1090 ΔltgA/ΔltgD (KK) has a similar in vivo phenotype as FA1090 ΔltgA/ΔltgD (JD). 
BALB/c mice were infected with either FA1090 or FA1090 ΔltgA/ΔltgD (KK) and 
bacterial burden was monitored daily with vaginal swabs as described in Chapter 3.  Notably, 
bacterial burdens for both wild type FA1090 and FA1090 ΔltgA/ΔltgD (KK) were lower than is 
typically observed in these experiments.  In addition, an unusually low number of mice were 
successfully infected with N. gonorrhoeae, resulting in a low number of subjects for analysis.  
The bacterial burden of FA1090 ΔltgA/ΔltgD (KK) is trending lower than that of FA1090, 
though the difference in area under the curve (AUC) between the mutant and wild type is not 
statistically significant (Panel A and B, P = 0.1027).  As observed with FA1090 ΔltgA/ΔltgD 
(JD), infection persistence was similar between FA1090 and FA1090 ΔltgA/ΔltgD (KK) (Panel 
C).  Additional experiments are needed to increase the number of animals in each group and 




Preliminary data shows that FA1090 ΔltgA/ΔltgD (KK) has a similar in vivo phenotype as 
FA1090 ΔltgA/ΔltgD (JD).   
A) Amount of N. gonorrhoeae recovered from mice on each day.  Graph shows data for mice 
known to be colonized with N. gonorrhoeae. A value of ½ lower limit of detection (LLD) was 
used when N. gonorrhoeae was not recovered from a mouse on one day but was recovered on a 
subsequent day.  B) Area under the curve (AUC) of bacterial burden for each mouse over the 
course of the experiment.  C) Persistence of infection. Data shown are a combination of two 
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